U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997.

Cover of Retroviruses

Retroviruses.

Show details

References

  1. Abeijon C., Hirschberg C.B. Topography of initiation of N-glycosylation reactions. J. Biol. Chem. 1990;265:14691–14695. [PubMed: 2117613]
  2. Aberham C., Weber S., Phares W. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J. Virol. 1996;70:3536–3544. [PMC free article: PMC190228] [PubMed: 8648687]
  3. Adam M.A., Miller A.D. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 1988;62:3802–3806. [PMC free article: PMC253525] [PubMed: 3418786]
  4. Adkins B., Hunter T. Identification of a packaged cellular mRNA in virions of Rous sarcoma virus. J. Virol. 1981;39:471–480. [PMC free article: PMC171357] [PubMed: 6268836]
  5. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 1995;69:5048–5056. [PMC free article: PMC189322] [PubMed: 7541845]
  6. Aiken C., Konner J., Landau N.R., Lenburg M.E., Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 1994;76:853–864. [PubMed: 8124721]
  7. Aldovini A., Young R.A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 1990;64:1920–1926. [PMC free article: PMC249345] [PubMed: 2109098]
  8. Alford R.L., Honda S., Lawrence C.B., Belmont J.W. RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus. Virology. 1991;183:611–619. [PubMed: 1853563]
  9. Almog N., Roller R., Arad G., Passi E.L., Wainberg M.A., Kotler M. A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1. J. Virol. 1996;70:7228–7232. [PMC free article: PMC190778] [PubMed: 8794372]
  10. Aloia R.C., Tian H., Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. 1993;99:5181–5185. [PMC free article: PMC46679] [PubMed: 8389472]
  11. Anderson D.J., Lee P., Levine K.L., Sang J.S., Shah S.A., Yang O.O., Shank P.R., Linial M.L. Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b. J. Virol. 1992;66:204–216. [PMC free article: PMC238277] [PubMed: 1727484]
  12. Anderson E.D., Thomas L., Hayflick J.S., Thomas G. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed α 1-antitrypsin variant. J. Biol. Chem. 1993;268:24887–24891. [PubMed: 8227051]
  13. Anderson K.P., Lie Y.S., Low M.A., Williams S.R., Fennie E.H., Nguyen T.P., Wurm F.M. Presence and transcription of intracisternal A-particle-related sequences in CHO cells. J. Virol. 1990;64:2021–2032. [PMC free article: PMC249357] [PubMed: 2109099]
  14. Anderson S.J., Lenburg M., Landau N.R., Garcia J.V. The cytoplasmic domain of CD4 is sufficient for its downregulation from the cell surface by human immunodeficiency virus type 1 Nef. J. Virol. 1994;68:3092–3101. [PMC free article: PMC236799] [PubMed: 8151774]
  15. Anderson S., Shugars D.C., Swanstrom R., Garcia J.V. Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J. Virol. 1993;67:4923–4931. [PMC free article: PMC237880] [PubMed: 8331733]
  16. Appelt K. Crystal structures of HIV-1 protease-inhibitor complexes. Perspect. Drug Discov. Des. 1993;1:23–48.
  17. Araya A., Sarih L., Litvak S. Reverse transcriptase mediated binding of primer tRNA to the viral genome. Nucleic Acids Res. 1979;6:3831–3843. [PMC free article: PMC327981] [PubMed: 91158]
  18. Aronoff R., Linial M. Specificity of retroviral RNA packaging. J. Virol. 1991;65:71–80. [PMC free article: PMC240490] [PubMed: 1985218]
  19. Aronoff R., Hajjar A.M., Linial M.L. Avian retroviral RNA encapsidation: Reexamination of functional 5′ RNA sequences and the role of nucleocapsid Cys-His motifs. J. Virol. 1993;67:178–188. [PMC free article: PMC237350] [PubMed: 8380070]
  20. Ashorn P., McQuade T.J., Thaisrivongs S., Tomasselli A.G., Tarpley W.G., Moss B. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc. Natl. Acad. Sci. 1990;87:7472–7476. [PMC free article: PMC54769] [PubMed: 2217178]
  21. Audoly G., Sauze N., Harkiss G., Vitu C., Russo P., Querat G., Suzan M., Vigne R. Identification and subcellular localization of the Q gene product of visna virus. Virology. 1992;189:734–739. [PubMed: 1322597]
  22. Awang G., Sen D. Mode of dimerization of HIV-1 genomic RNA. Biochemistry. 1993;32:11453–11457. [PubMed: 8218211]
  23. Baboonian C., Dalgleish A., Bountiff L., Gross J., Oroszlan S., Rickett G., Smith B.C., Troke P., Merson J. HIV-1 proteinase is required for synthesis of proviral DNA. Biochem. Biophys. Res. Commun. 1991;179:17–24. [PubMed: 1652947]
  24. Baca M., Kent S.B. Catalytic contribution of flap-substrate hydrogen bonds in “HIV-1 protease” explored by chemical synthesis. Proc. Natl. Acad. Sci. 1993;90:11638–11642. [PMC free article: PMC48039] [PubMed: 8265601]
  25. Baca M., Alewood P.F., Kent S.B. Structural engineering of the HIV-1 protease molecule with a β-turn mimic of fixed geometry. Protein Sci. 1993;2:1085–1091. [PMC free article: PMC2142420] [PubMed: 8358291]
  26. Balliet J.W., Kolson D.L., Eiger G., Kim F.M., McGann K.A., Srinivasan A., Collman R. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: Mutational analysis of a primary HIV-1 isolate. Virology. 1994;200:623–631. [PubMed: 8178448]
  27. Barat C., Le Grice S.F., Darlix J.L. Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNALys,3. Nucleic Acids Res. 1991;19:751–757. [PMC free article: PMC333707] [PubMed: 1708122]
  28. Barat C., Lullien V., Schatz O., Keith G., Nugeyre M.T., Gruninger-Leitch L.F., Barré-Sinoussi F., Le Grice S.F., Darlix J.L. HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 1989;8:3279–3285. [PMC free article: PMC401457] [PubMed: 2479543]
  29. Barr P.J. Mammalian subtilisins: The long-sought dibasic processing endoproteases. Cell. 1991;66:1–3. [PubMed: 2070411]
  30. Bartenschlager R., Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 1992;11:3413–3420. [PMC free article: PMC556876] [PubMed: 1380455]
  31. Bates P., Young J.A., Varmus H.E. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell. 1993;74:1043–1051. [PubMed: 8402880]
  32. Baudin F., Marquet R., Isel C., Darlix J.L., Ehresmann B., Ehresmann C. Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 1993;229:382–397. [PubMed: 8429553]
  33. Becker J., Craig E.A. Heat-shock proteins as molecular chaperones. Eur. J. Biochem. 1994;219:11–23. [PubMed: 8306977]
  34. Bedgood R.M., Stallcup M.R. A novel intermediate in processing of murine leukemia virus envelope glycoproteins: Proteolytic cleavage in the late Golgi region. J. Biol. Chem. 1992;267:7060–7065. [PubMed: 1313032]
  35. Bender M.A., Palmer T.D., Gelinas R.E., Miller A.D. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 1987;61:1639–1646. [PMC free article: PMC254146] [PubMed: 3502707]
  36. Bender W., Davidson N. Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell. 1976;7:595–607. [PubMed: 182376]
  37. Bender W., Chien Y.H., Chattopadhyay S., Vogt P.K., Gardner M.B., Davidson N. High-molecular-weight RNAs of AKR, NZB, wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J. Virol. 1978;25:888–896. [PMC free article: PMC525983] [PubMed: 205678]
  38. Bennett R.P., Nelle T.D., Wills J.W. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 1993;67:6487–6498. [PMC free article: PMC238085] [PubMed: 8411352]
  39. Bennett R.P., Rhee S., Craven R.C., Hunter E., Wills J.W. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly. J. Virol. 1991;65:272–280. [PMC free article: PMC240514] [PubMed: 1845888]
  40. Benson R.E., Sanfridson A., Ottinger J.S., Doyle C., Cullen B.R. Down regulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 1993;177:1561–1566. [PMC free article: PMC2191034] [PubMed: 8098729]
  41. Bergeron J.J., Brenner M.B., Thomas D.Y., Williams D.B. Calnexin: A membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 1994;19:124–128. [PubMed: 8203019]
  42. Berkhout B., van Wamel J.L.B. Role of the DIS hairpin in replication of human immunodeficiency virus type 1. J. Virol. 1996;70:6723–6732. [PMC free article: PMC190715] [PubMed: 8794309]
  43. Berkhout B., Essink B.B., Schoneveld I. In vitro dimerization of HIV-2 leader RNA in the absence of PuGGAPuA motifs. FASEB J. 1993;7:181–187. [PubMed: 8422965]
  44. Berkowitz R.D., Goff S.P. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. Virology. 1994;202:233–246. [PubMed: 8009834]
  45. Berkowitz R., Fisher J., Goff S.P. RNA packaging. Curr. Top. Microbiol. Immunol. 1996;214:177–218. [PubMed: 8791728]
  46. Berkowitz R.D., Luban J., Goff S.P. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 1993;67:7190–7200. [PMC free article: PMC238181] [PubMed: 8230441]
  47. Berkowitz R.D., Ohagen A., Höglund S., Goff S.P. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J. Virol. 1995a;69:6445–6456. [PMC free article: PMC189545] [PubMed: 7666546]
  48. Berkowitz R.D., Hammarskjold M.L., Helga M.C., Rekosh D., Goff S.P. 5′ Regions of human immunodeficiency virus type 1 RNAs are not sufficient for encapsidation: Implications for the human immunodeficiency virus type 1 packaging signal. Virology. 1995b;212:718–723. [PubMed: 7571442]
  49. Berlioz C., Darlix J.L. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J. Virol. 1995;69:2214–2222. [PMC free article: PMC188890] [PubMed: 7884868]
  50. Berman P.W., Nunes W.M., Haffar O.K. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines. J. Virol. 1988;62:3135–3142. [PMC free article: PMC253430] [PubMed: 2841466]
  51. Bernstein H.B., Compans R.W. Sulfation of the human immunodeficiency virus envelope glycoprotein. J. Virol. 1992;66:6953–6959. [PMC free article: PMC240329] [PubMed: 1433500]
  52. Bernstein H.B., Tucker S.P., Hunter E., Schutzbach J.S., Compans R.W. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 1994;68:463–468. [PMC free article: PMC236307] [PubMed: 8254757]
  53. Bernstein H.B., Tucker S.P., Kar S.R., McPherson S.A., McPherson D.T., Dubay J.W., Lebowitz J., Compans R.W., Hunter E. Oligomerization of the hydrophobic heptad repeat of gp41. J. Virol. 1995;69:2745–2750. [PMC free article: PMC188967] [PubMed: 7707497]
  54. Bess J.W. Jr., Powell P.J., Issaq H.J., Schumack L.J., Grimes M.K., Henderson L.E., Arthur L.O. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1 and other retroviruses. J. Virol. 1992;66:840–847. [PMC free article: PMC240784] [PubMed: 1731111]
  55. Bieth E., Gabus C., Darlix J.L. A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro. Nucleic Acids Res. 1990;18:119–27. [PMC free article: PMC330211] [PubMed: 2155394]
  56. Billich A., Winkler G. Analysis of subsite preferences of HIV-1 proteinase using MA/CA junction peptides substituted at the P3-P1′positions. Arch. Biochem. Biophys. 1991;290:186–190. [PubMed: 1898088]
  57. Billich S., Knoop M.T., Hansen J., Strop P., Sedlacek J., Mertz R., Moelling K. Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease. J. Biol. Chem. 1988;263:17905–17908. [PubMed: 3056930]
  58. Bird C., Gleeson P.A., Ramsay A., Li P., McCluskey J. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells. AIDS Res. Hum. Retroviruses. 1992;8:1999–2009. [PubMed: 1493050]
  59. Bishop W.R., Bell R.M. Assembly of phospholipids into cellular membranes: Biosynthesis, transmembrane movement and intracellular translocation. Annu. Rev. Cell Biol. 1988;4:579–610. [PubMed: 3058167]
  60. Bishop J.M., Levinson W.E., Quintrell N., Sullivan D., Fanshier L., Jackson J. The low molecular weight RNAs of Rous sarcoma virus. II. The 7 S RNA. Virology. 1970a;42:927–937. [PubMed: 4321311]
  61. Bishop J.M., Levinson W.E., Sullivan D., Fanshier L., Quintrell N., Jackson J. The low molecular weight RNA's of Rous sarcoma virus. I. The 4 S RNA. Virology. 1970b;42:182–195. [PubMed: 4318979]
  62. Bizub D., Katz R.A., Skalka A.M. Nucleotide sequence of noncoding regions in Rous-associated virus-2: Comparisons delineate conserved regions important in replication and oncogenesis. J. Virol. 1984;49:557–565. [PMC free article: PMC255497] [PubMed: 6319755]
  63. Blanc D., Patience C., Schulz T.F., Weiss R., Spire B. Transcomplementation of VIF-HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. Virology. 1993;193:186–192. [PubMed: 8438565]
  64. Blond-Elguindi S., Cwirla S.E., Dower W.J., Lipshutz R.J., Sprang S.R., Sambrook J.F., Gething M.-J.H. Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell. 1993;75:717–728. [PubMed: 7902213]
  65. Bolognesi D.P., Montelaro R.C., Frank H., Schafer W. Assembly of type C oncornaviruses: A model. Science. 1978;199:183–186. [PubMed: 202022]
  66. Bork P., Sudol M. The WW domain: A signalling site in dystrophin? Trends Biochem. Sci. 1994;19:531–533. [PubMed: 7846762]
  67. Borman A.M., Quillent C., Charneau P., Dauguet C., Clavel F. Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity. J. Virol. 1995;69:2058–2067. [PMC free article: PMC188871] [PubMed: 7884851]
  68. Bosch M.L., Earl P.L., Fargnoli K., Picciafuoco S., Giombini F., Wong-Staal F., Franchini G. Identification of the fusion peptide of primate immunodeficiency viruses. Science. 1989;244:694–697. [PubMed: 2541505]
  69. Bour S., Strebel K. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 1996;70:8285–8300. [PMC free article: PMC190916] [PubMed: 8970948]
  70. Bour S., Boulerice F., Wainberg M.A. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J. Virol. 1991;65:6387–6396. [PMC free article: PMC250675] [PubMed: 1942241]
  71. Bour S., Schubert U., Strebel K. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: Implications for the mechanism of degradation. J. Virol. 1995;69:1510–1520. [PMC free article: PMC188742] [PubMed: 7853484]
  72. Bour S., Schubert U., Peden K., Strebel K. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: A Vpu-like factor? J. Virol. 1996;70:820–829. [PMC free article: PMC189884] [PubMed: 8551620]
  73. Bouyac M., Rey F., Nascimbeni M., Courcoul M., Sire J., Blanc D., Clavel F., Vigne R., Spire B. Phenotypically Vif-human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 1997;71:2473–2477. [PMC free article: PMC191358] [PubMed: 9032385]
  74. Bowles N.E., Damay P., Spahr P.F. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 1993;67:623–631. [PMC free article: PMC237413] [PubMed: 8380458]
  75. Bowles N., Bonnet D., Mulhauser F., Spahr P.F. Site-directed mutagenesis of the P2 region of the Rous sarcoma virus gag gene: Effects on Gag polyprotein processing. Virology. 1994;203:20–28. [PubMed: 8030280]
  76. Braaten D., Franke E.K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 1996;70:3551–3560. [PMC free article: PMC190230] [PubMed: 8648689]
  77. Bradac J., Hunter E. Polypeptides of Mason-Pfizer monkey virus. II. Synthesis and processing of the env gene products. Virology. 1986;150:491–502. [PubMed: 3083581]
  78. Brierley I., Digard P., Inglis S.C. Characterization of an efficient coronavirus ribosomal frameshifting signal: Requirement for an RNA pseudoknot. Cell. 1989;57:537–547. [PMC free article: PMC7133225] [PubMed: 2720781]
  79. Brody B.A., Hunter E. Mutations within the env gene of Mason-Pfizer monkey virus: Effects on protein transport and SU-TM association. J. Virol. 1992;66:3466–3475. [PMC free article: PMC241127] [PubMed: 1316462]
  80. Brody B.A., Kimball M.G., Hunter E. Mutations within the transmembrane glycoprotein of Mason-Pfizer monkey virus: Loss of SU-TM association and effects on infectivity. Virology. 1994a;202:673–683. [PubMed: 8030233]
  81. Brody B.A., Rhee S.S., Hunter E. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 1994b;68:4620–4627. [PMC free article: PMC236389] [PubMed: 8207836]
  82. Brody B.A., Rhee S.S., Sommerfelt M.A., Hunter E. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc. Natl. Acad. Sci. 1992;89:3443–3447. [PMC free article: PMC48884] [PubMed: 1565636]
  83. Bryant M., Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. 1990;87:523–527. [PMC free article: PMC53297] [PubMed: 2405382]
  84. Buchschacher G.L.J., Panganiban A.T. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 1992;66:2731–2739. [PMC free article: PMC241028] [PubMed: 1560523]
  85. Bugelski P.J., Maleeff B.E., Klinkner A.M., Ventre J., Hart T.K. Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1. AIDS Res. Hum. Retroviruses. 1995;11:55–64. [PubMed: 7734197]
  86. Bukovsky A., Göttlinger H. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J. Virol. 1996;70:6820–6825. [PMC free article: PMC190728] [PubMed: 8794322]
  87. Bukovsky A.A., Dorfman T., Weimann A., Göttlinger H.G. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 1997;71:1013–1018. [PMC free article: PMC191151] [PubMed: 8995620]
  88. Bukrinskaya A.G., Ghorpade A., Heinzinger N.K., Smithgall T.E., Lewis R.E., Stevenson M. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. 1996;93:367–371. [PMC free article: PMC40239] [PubMed: 8552640]
  89. Bukrinsky M.I., Sharova N., McDonald T.L., Pushkarskaya T., Tarpley W.G., Stevenson M. Association of integrase, matrix, reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infeciton. Proc. Natl. Acad. Sci. 1993a;90:6125–6129. [PMC free article: PMC46880] [PubMed: 7687060]
  90. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubel A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of nondividing cells. Nature. 1993b;365:666–669. [PMC free article: PMC9524217] [PubMed: 8105392]
  91. Bullough P.A., Hughson F.M., Skehel J.J., Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 1994;371:37–43. [PubMed: 8072525]
  92. Buonocore L., Rose J.K. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature. 1990;345:625–628. [PubMed: 2190096]
  93. Burstein H., Bizub D., Skalka A.M. Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers. J. Virol. 1991;65:6165–6172. [PMC free article: PMC250303] [PubMed: 1656090]
  94. Burstein H., Bizub D., Kotler M., Schatz G., Vogt V.M., Skalka A.M. Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site. J. Virol. 1992;66:1781–1785. [PMC free article: PMC240938] [PubMed: 1310781]
  95. Buser C.A., Sigal C.T., Resh M.D., McLaughlin S. Membrane binding of myristylated peptides corresponding to the NH2 terminus of Src. Biochemistry. 1994;33:13093–13101. [PubMed: 7947714]
  96. Camaur D., Trono D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 1996;70:6106–6111. [PMC free article: PMC190632] [PubMed: 8709234]
  97. Cameron C.E., Grinde B., Jacques P., Jentoft J., Leis J., Wlodawer A., Weber I.T. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. J. Biol. Chem. 1993;268:11711–11720. [PubMed: 8389361]
  98. Cameron C.E., Ridky T.W., Shulenin S., Leis J., Weber I.T., Copeland T., Wlodawer A., Burstein H., Bizub B.D., Skalka A.M. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases. J. Biol. Chem. 1994;269:11170–11177. [PubMed: 8157644]
  99. Campbell S., Vogt V.M. Self assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus-1. J. Virol. 1995;69:6487–6497. [PMC free article: PMC189550] [PubMed: 7666550]
  100. Campbell S., Vogt V.M. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: Identification of the p10 domain as a morphological determinant in the formation of spherical particles. J. Virol. 1997;71:4425–4435. [PMC free article: PMC191661] [PubMed: 9151833]
  101. Canaani E., von der Helm K., Duesberg P. Evidence for 30–40S RNA as precursor of the 60–70S RNA of Rous sarcoma virus. Proc. Natl. Acad. Sci. 1973;70:401–405. [PMC free article: PMC433269] [PubMed: 4119788]
  102. Carrière C., Gay B., Chazal N., Morin N., Boulanger P. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles. J. Virol. 1995;69:2366–2377. [PMC free article: PMC188909] [PubMed: 7884882]
  103. Cassan M., Delaunay N., Vaquero C., Rousset J.P. Translational frameshifting at the gag-pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells. J. Virol. 1994;68:1501–1508. [PMC free article: PMC236606] [PubMed: 7906312]
  104. Cepko C., Roberts B., Mulligan R. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell. 1984;37:1053–1062. [PubMed: 6331674]
  105. Chamorro M., Parkin N., Varmus H.E. An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA. Proc. Natl. Acad. Sci. 1992;89:713–717. [PMC free article: PMC48309] [PubMed: 1309954]
  106. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 1997;89:263–273. [PubMed: 9108481]
  107. Chazal N., Carrière C., Gay B., Boulanger P. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J. Virol. 1994;68:111–122. [PMC free article: PMC236270] [PubMed: 8254720]
  108. Chen H.I., Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. 1995;92:7819–7823. [PMC free article: PMC41237] [PubMed: 7644498]
  109. Chen M.Y., Maldarelli F., Karczewsik M.K., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: The cytoplasmic domain of CD4 contributes to Vpu sensitivity. J. Virol. 1993;67:3877–3884. [PMC free article: PMC237753] [PubMed: 8510209]
  110. Chen X., Chamorro M., Lee S.I., Shen L.X., Hines J.V., Tinoco I.J., Varmus H.E. Structural and functional studies of retroviral RNA pseudoknots involved in ribosomal frameshifting: Nucleotides at the junction of the two stems are important for efficient ribosomal frameshifting. EMBO J. 1995;14:842–852. [PMC free article: PMC398151] [PubMed: 7882986]
  111. Cheong C., Varani G., Tinoco I.J. Solution structure of an unusually stable RNA hairpin, 5′ GGAC(UUCG)GUCC. Nature. 1990;346:680–682. [PubMed: 1696688]
  112. Cheung K.S., Smith R.E., Stone M.P., Joklik W.K. Comparison of immature (rapid harvest) and mature Rous sarcoma virus particles. Virology. 1972;50:851–864. [PubMed: 4344944]
  113. Chou K.C. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J. Biol. Chem. 1993;268:16938–16948. [PubMed: 8349584]
  114. Clare J., Farabaugh P. Nucleotide sequence of a yeast Ty element: Evidence for an unusual mechanism of gene expression. Proc. Natl. Acad. Sci. 1985;82:2829–2833. [PMC free article: PMC397659] [PubMed: 2581255]
  115. Clavel F., Orenstein J.M. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J. Virol. 1990;64:5230–5234. [PMC free article: PMC248025] [PubMed: 2204725]
  116. Clever J.L., Parslow T.G. Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J. Virol. 1997;71:3407–3414. [PMC free article: PMC191485] [PubMed: 9094610]
  117. Clever J., Sassetti C., Parslow T.G. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 1995;69:2101–2109. [PMC free article: PMC188876] [PubMed: 7884856]
  118. Clever J.L., Wong M.L., Parslow T.G. Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA. J. Virol. 1996;70:5902–5908. [PMC free article: PMC190608] [PubMed: 8709210]
  119. Co E., Koelsch G., Lin Y., Ido E., Hartsuck J.A., Tang J. Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1. Biochemistry. 1994;33:1248–1254. [PubMed: 8110758]
  120. Coffin J.M. 1992Structure and classification of retroviruses In The retroviridae (ed. J.A. Levy), pp. 19–49. Plenum Press, New York.
  121. Cohen E.A., Subbramanian R.A., Göttlinger H.G. Role of auxiliary proteins in retroviral morphogenesis. Curr. Top. Microbiol. Immunol. 1996;214:219–235. [PubMed: 8791729]
  122. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 1990a;64:3097–3099. [PMC free article: PMC249501] [PubMed: 2139896]
  123. Cohen E.A., Terwilliger E.F., Sodroski J.G., Haseltine W.A. Identification of a protein encoded by the vpu gene of HIV-1. Nature. 1988;334:532–524. [PubMed: 3043230]
  124. Cohen E.A., Terwilliger E.F., Jalinoos Y., Proulx J., Sodroski J.G., Haseltine W.A. Identification of HIV-1 vpr product and function. J. Acquired Immune Defic. Syndr. 1990b;3:11–18. [PubMed: 2136707]
  125. Colicelli J., Goff S.P. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 1986;57:37–45. [PMC free article: PMC252696] [PubMed: 2416955]
  126. Corbin A., Prats A.C., Darlix J.L., Sitbon M. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J. Virol. 1994;68:3857–3867. [PMC free article: PMC236891] [PubMed: 8189523]
  127. Cordell B., Swanstrom R., Goodman H.M., Bishop J.M. tRNATrp as primer for RNA-directed DNA polymerase: Structural determinants of function. J. Biol. Chem. 1979;254:1866–1874. [PubMed: 84811]
  128. Craven R.C., Parent L.J. Dynamic interactions of the Gag polyprotein. Curr. Top. Microbiol. Immunol. 1996;214:65–94. [PubMed: 8791725]
  129. Craven R.C., Bennett R.P., Wills J.W. Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly. J. Virol. 1991;65:6205–6217. [PMC free article: PMC250313] [PubMed: 1717718]
  130. Craven R.C., Leure-duPree A.E., Weldon R.A., Wills J.W. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 1995;69:4213–4227. [PMC free article: PMC189159] [PubMed: 7769681]
  131. Craven R.C., Leure-duPree A.E., Erdie C.R., Wilson C.B., Wills J.W. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus Gag protein. J. Virol. 1993;67:6246–6252. [PMC free article: PMC238047] [PubMed: 8396679]
  132. Crawford S., Goff S.P. A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J. Virol. 1985;53:899–907. [PMC free article: PMC254725] [PubMed: 3882995]
  133. Crise B., Rose J.K. Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum. J. Virol. 1992;66:2296–2301. [PMC free article: PMC289024] [PubMed: 1548763]
  134. Crise B., Buonocore L., Rose J.K. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein receptor. J. Virol. 1990;64:5585–5593. [PMC free article: PMC248611] [PubMed: 2214026]
  135. Dannull J., Surovoy A., Jung G., Moelling K. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 1994;13:1525–1533. [PMC free article: PMC394981] [PubMed: 8156990]
  136. Darke P.L., Nutt R.F., Brady S.F., Garsky V.M., Ciccarone T.M., Leu C.T., Lumma P.K., Freidinger R.M., Veber D.F., Sigal I.S. HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. Biochem. Biophys. Res. Commun. 1988;156:297–303. [PubMed: 3052448]
  137. Darlix J.L., Gabus C., Allain B. Analytical study of avian reticuloendotheliosis virus dimeric RNA generated in vivo and in vitro. J. Virol. 1992;66:7245–7252. [PMC free article: PMC240428] [PubMed: 1331519]
  138. Darlix J.L., Gabus C., Nugeyre M.T., Clavel F., Barré-Sinoussi F. cis Elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 1990;216:689–699. [PubMed: 2124274]
  139. Das A., Klaver B., Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNALys 3. J. Virol. 1995;69:3090–3097. [PMC free article: PMC189010] [PubMed: 7707537]
  140. Davies D.R. The structure and function of the aspartic proteinases. Annu. Rev. Biophys. Biophys. Chem. 1990;19:189–215. [PubMed: 2194475]
  141. Debouck C., Gorniak J.G., Strickler J.E., Meek T.D., Metcalf B.W., Rosenberg M. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc. Natl. Acad. Sci. 1987;84:8903–8906. [PMC free article: PMC299659] [PubMed: 3321060]
  142. Decroly E., Vandenbranden M., Ruysschaert J.M., Cogniaux J., Jacob G.S., Howard S.C., Marshall G., Kompelli A., Basak A., Jean F. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J. Biol. Chem. 1994;269:12240–12247. [PubMed: 8163529]
  143. Delahunty M.D., Wilson S.H., Karpel R.L. Studies on primer binding of human immunodeficiency virus type 1 reverse transcriptase using a fluorescent probe. J. Mol. Biol. 1994;236:469–479. [PubMed: 7508989]
  144. Delchambre M., Gheysen D., Thines D., Thiriart C., Jacobs E., Verdin E., Horth M., Burny A., Bex F. The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 1989;8:2653–2660. [PMC free article: PMC401271] [PubMed: 2684654]
  145. Delwart E.L., Panganiban A.T. Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J. Virol. 1989;63:273–280. [PMC free article: PMC247682] [PubMed: 2535733]
  146. Delwart E.L., Panganiban A.T. N-linked glycosylation and reticuloendotheliosis retrovirus envelope glycoprotein function. Virology. 1990;179:648–657. [PubMed: 2173257]
  147. Deminie C.A., Emerman M. Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions. J. Virol. 1993;67:6499–6506. [PMC free article: PMC238086] [PubMed: 8411353]
  148. Deminie C.A., Emerman M. Functional exchange of an oncoretrovirus and a lentivirus matrix protein. J. Virol. 1994;68:4442–4449. [PMC free article: PMC236369] [PubMed: 8207817]
  149. De Rocquigny H., Gabus C., Vincent A., Fournie-Zaluski M.C., Roques B., Darlix J.L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. 1992;89:6472–6476. [PMC free article: PMC49523] [PubMed: 1631144]
  150. De Rocquigny H., Ficheux D., Gabus C., Allain B., Fournie-Zaluski M.C., Darlix J.L., Roques B.P. Two short basic sequences surrounding the zinc finger of nucleocapsid protein NCp10 of Moloney murine leukemia virus are critical for RNA annealing activity. Nucleic Acids Res. 1993;21:823–829. [PMC free article: PMC309213] [PubMed: 8451185]
  151. Dickson C., Atterwill M. Polyproteins related to the major core protein of mouse mammary tumor virus. J. Virol. 1978;26:660–672. [PMC free article: PMC525890] [PubMed: 78987]
  152. Dickson C., Atterwill M. Composition, arrangement and cleavage of the mouse mammary tumor virus polyprotein precursor Pr77gag and p110gag. Cell. 1979;17:1003–1012. [PubMed: 226264]
  153. Dickson C., Eisenman R., Fan H., Hunter E., Teich N. 1984Protein biosynthesis and assembly In Molecular biology of tumor viruses, 2nd edition: RNA tumor viruses 1/Text (ed. R. Weiss et al.), pp. 13–648. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
  154. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N.R. Mutational analysis of cell cycle arrest, nuclear localization, virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 1995;69:7909–7916. [PMC free article: PMC189735] [PubMed: 7494303]
  155. di Marzo Veronese F., Copeland T.D., DeVico A.L., Rahman R., Oroszlan S., Gallo R.C., Sarngadharan M.G. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science. 1986;231:1289–1291. [PubMed: 2418504]
  156. Dittmar K.J., Moelling K. Biochemical properties of p15-associated protease in an avian RNA tumor virus. J. Virol. 1978;28:106–118. [PMC free article: PMC354252] [PubMed: 212597]
  157. Doms R.W., Earl P.L., Chakrabarti S., Moss B. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Env proteins possess a functionally conserved assembly domain. J. Virol. 1990;64:3537–3540. [PMC free article: PMC249626] [PubMed: 2352332]
  158. Doms R.W., Lamb R.A., Rose J.K., Helenius A. Folding and assembly of viral membrane proteins. Virology. 1993;193:545–562. [PubMed: 8460475]
  159. Dong J., Roth M.G., Hunter E. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J. Virol. 1992a;66:7374–7382. [PMC free article: PMC240443] [PubMed: 1331528]
  160. Dong J.Y., Dubay J.W., Perez L.G., Hunter E. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J. Virol. 1992b;66:865–874. [PMC free article: PMC240787] [PubMed: 1370559]
  161. Donzé O., Spahr P.F. Role of the open reading frames of Rous sarcoma virus leader RNA in translation and genome packaging. EMBO J. 1992;11:3747–3757. [PMC free article: PMC556835] [PubMed: 1327749]
  162. Doolittle R.F., Feng D.F., Johnson M.S., McClure M.A. Origins and evolutionary relationships of retroviruses. Q. Rev. Biol. 1989;64:1–30. [PubMed: 2469098]
  163. Dorfman T., Mammano F., Haseltine W.A., Gottlinger H.G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 1994a;68:1689–1696. [PMC free article: PMC236628] [PubMed: 8107229]
  164. Dorfman T., Bukovsky A., Ohagen A., Hoglund S., Gottlinger H.G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 1994b;68:8180–8187. [PMC free article: PMC237283] [PubMed: 7966609]
  165. Dorfman T., Luban J., Goff S.P., Haseltine W.A., Göttlinger H.G. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 1993;67:6159–6169. [PMC free article: PMC238038] [PubMed: 8371356]
  166. Dornburg R., Temin H.M. Retroviral vector system for the study of cDNA gene formation. Mol. Cell. Biol. 1988;8:2328–2334. [PMC free article: PMC363430] [PubMed: 2457150]
  167. Dornburg R., Temin H.M. Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes. J. Virol. 1990;64:886–889. [PMC free article: PMC249185] [PubMed: 2153250]
  168. Dorner A.J., Bonneville F., Kriz R., Kelleher K., Bean K., Kaufman R.J. Molecular cloning and characterization of a complete Chinese hamster provirus related to intracisternal A particle genomes. J. Virol. 1991;65:4713–4719. [PMC free article: PMC248927] [PubMed: 1908027]
  169. Dreyer G.B., Boehm J.C., Chenera B., DesJarlais R.L., Hassell A.M., Meek T.D., Tomaszek T.A.J., Lewis M. A symmetric inhibitor binds HIV-1 protease asymmetrically. Biochemistry. 1993;32:937–947. [PubMed: 8422397]
  170. Dubay J.W., Roberts S.J., Brody B., Hunter E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 1992a;66:4748–4756. [PMC free article: PMC241301] [PubMed: 1629954]
  171. Dubay J.W., Roberts S.J., Hahn B.H., Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 1992b;66:6616–6625. [PMC free article: PMC240157] [PubMed: 1357190]
  172. Dunn B.M., Gustchina A., Wlodawer A., Kay J. Subsite preferences of retroviral proteinases. Methods Enzymol. 1994;241:254–278. [PubMed: 7854181]
  173. Dupraz P., Spahr P.F. Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging. J. Virol. 1992;66:4662–4670. [PMC free article: PMC241290] [PubMed: 1378506]
  174. Dupraz P., Oertle S., Meric C., Damay P., Spahr P.F. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein. J. Virol. 1990;64:4978–4987. [PMC free article: PMC247989] [PubMed: 2168981]
  175. Duyk G., Leis J., Longiaru M., Skalka A.M. Selective cleavage in the avian retroviral long terminal repeat sequence by the endonuclease associated with the αβ form of avian reverse transcriptase. Proc. Natl. Acad. Sci. 1983;80:6745–6749. [PMC free article: PMC390062] [PubMed: 6196775]
  176. Earl P.L., Moss B. Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein. AIDS Res. Hum. Retroviruses. 1993;9:589–594. [PubMed: 8369163]
  177. Earl P.L., Doms R.W., Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. 1990;87:648–652. [PMC free article: PMC53322] [PubMed: 2300552]
  178. Earl P.L., Moss B., Doms R.W. Folding, interaction with GRP78-BiP, assembly, transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 1991;65:2047–2055. [PMC free article: PMC240054] [PubMed: 1900540]
  179. Edbauer C.A., Naso R.B. Cytoskeleton-associated Pr65gag and retrovirus assembly. Virology. 1983;130:415–426. [PubMed: 6196908]
  180. Edbauer C.A., Naso R.B. Cytoskeleton-associated Pr65gag and assembly of retrovirus temperature-sensitive mutants in chronically infected cells. Virology. 1984;134:389–397. [PubMed: 6336230]
  181. Edwards S.A., Fan H. gag-related polyproteins of Moloney-murine leukemia virus: Evidence for independent synthesis of glycosylated and unglycosylated forms. J. Virol. 1979;30:551–563. [PMC free article: PMC353359] [PubMed: 469993]
  182. Egan M.A., Carruth L.M., Rowell J.F., Yu X., Siliciano R.F. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J. Virol. 1996;70:6547–6556. [PMC free article: PMC190695] [PubMed: 8794289]
  183. Ehrlich L.S., Agresta B.E., Carter C.A. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 1992;66:4874–4883. [PMC free article: PMC241323] [PubMed: 1629958]
  184. Einfeld D., Hunter E. Oligomeric structure of a prototype retrovirus glycoprotein. Proc. Natl. Acad. Sci. 1988;85:8688–8692. [PMC free article: PMC282525] [PubMed: 2847170]
  185. Einfeld D., Hunter E. Transport of membrane proteins to the cell surface. Curr. Top. Microbiol. Immunol. 1991;170:107–139. [PubMed: 1760929]
  186. Einfeld D., Hunter E. Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport. J. Virol. 1994;68:2513–2520. [PMC free article: PMC236729] [PubMed: 8139033]
  187. Eisenman R., Mason W.S., Linial M. Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviurses. J. Virol. 1980;36:62–78. [PMC free article: PMC353616] [PubMed: 6160263]
  188. Embretson J.E., Temin H.M. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 1987;61:2675–2683. [PMC free article: PMC255771] [PubMed: 3039161]
  189. Engelman A., Englund G., Orenstein J., Martin M., Craigie R. Multiple effects of mutations in human immunodeficeincy virus type 1 integrase on viral replication. J. Virol. 1995;69:2729–2736. [PMC free article: PMC188965] [PubMed: 7535863]
  190. Englund G., Theodore T.S., Freed E.O., Engelman A., Martin M.A. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J. Virol. 1995;69:3216–3219. [PMC free article: PMC189028] [PubMed: 7707554]
  191. Erdie C.R., Wills J.W. Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells. J. Virol. 1990;64:5204–5208. [PMC free article: PMC248019] [PubMed: 2168997]
  192. Erickson J., Neidhart D.J., VanDrie J., Kempf D.J., Wang X.C., Norbeck D.W., Plattner J.J., Rittenhouse J.W., Turon M., Wideburg N., Kohlbrenner W.E., Helfrich R.S.R., Paul D.A., Knigge M. Design, activity, 2.8 Å crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science. 1990;249:527–533. [PubMed: 2200122]
  193. Erickson-Viitenan S., Manfredi J., Viitanen P., Tribe D.E., Tritch R., Hutchison C.A. III, Loeb D.D., Swanstrom R. Cleavage of HIV-1 gag polyprotein synthesized in vitro: Sequential cleavage by the viral protease. AIDS Res. Hum. Retroviruses. 1989;5:577–591. [PubMed: 2692658]
  194. Evans L.H., Dressler S., Kabat D. Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J. Virol. 1977;24:865–874. [PMC free article: PMC516008] [PubMed: 592467]
  195. Ewart G.D., Sutherland T., Gage P.W., Cox G.B. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 1996;70:7108–7115. [PMC free article: PMC190763] [PubMed: 8794357]
  196. Fäcke M., Janetzko A., Shoeman R.L., Kräusslich H.G. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 1993;67:4972–4980. [PMC free article: PMC237885] [PubMed: 8331736]
  197. Falk H., Mador N., Udi R., Panet A., Honigman A. Two cis-acting signals control ribosomal frameshift between human T-cell leukemia virus type II gag and pro genes. J. Virol. 1993;67:6273–6277. [PMC free article: PMC238052] [PubMed: 8371359]
  198. Fan L., Peden K. Cell-free transmission of Vif mutants of HIV-1. Virology. 1992;190:19–29. [PubMed: 1529528]
  199. Fan H., Chite H., Chao E., Feuerman M. Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated Gag polyprotein. Proc. Natl. Acad. Sci. 1983;80:5965–5969. [PMC free article: PMC390198] [PubMed: 6310608]
  200. Farmerie W.G., Loeb D.D., Casavant N.C., Hutchison C.A. III, Edgell M.H., Swanstrom R. Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science. 1987;236:305–308. [PubMed: 2436298]
  201. Federspiel M.J., Crittenden L.B., Hughes S.H. Expression of avian reticuloendotheliosis virus envelope confes host resistance. Virology. 1989;173:167–177. [PubMed: 2554569]
  202. Felkner R.H., Roth M.J. Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J. Virol. 1992;66:4258–4264. [PMC free article: PMC241230] [PubMed: 1318404]
  203. Felsenstein K.M., Goff S.P. Expression of the Gag-Pol fusion protein of Moloney murine leukemia virus without Gag protein does not induce virion formation or proteolytic processing. J. Virol. 1988;62:2179–2182. [PMC free article: PMC253323] [PubMed: 2452901]
  204. Felsenstein K.M., Goff S.P. Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: Requirements for expression of the gag-pol fusion protein. J. Virol. 1992;66:6601–6608. [PMC free article: PMC240155] [PubMed: 1404606]
  205. Feng Y.X., Hatfield D.L., Rein A., Levin J.G. Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA. J. Virol. 1989a;63:2405–2410. [PMC free article: PMC250668] [PubMed: 2784837]
  206. Feng Y.X., Yuan H., Rein A., Levin J.G. Bipartite signal for readthrough suppression in murine leukemia virus mRNA: An eight-nucleotide purine-rich sequence immediately downstream of the gag termination codon followed by an RNA pseudoknot. J. Virol. 1992;66:5127–5132. [PMC free article: PMC241386] [PubMed: 1629968]
  207. Feng Y.X., Copeland T.D., Oroszlan S., Rein A., Levin J.G. Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus. Proc. Natl. Acad. Sci. 1990;87:8860–8863. [PMC free article: PMC55059] [PubMed: 2247457]
  208. Feng Y.X., Fu W., Winter A.J., Levin J.G., Rein A. Multiple regions of Harvey sarcoma virus RNA can dimerize in vitro. J. Virol. 1995;69:2486–2490. [PMC free article: PMC188924] [PubMed: 7884897]
  209. Feng Y.X., Levin J.G., Hatfield D.L., Schaefer T.S., Gorelick R.J., Rein A. Suppression of UAA and UGA termination codons in mutant murine leukemia viruses. J. Virol. 1989b;63:2870–2873. [PMC free article: PMC250804] [PubMed: 2542597]
  210. Fenouillet E., Jones I.M. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J. Gen. Virol. 1995;76:1509–1514. [PubMed: 7782780]
  211. Fisher A.G., Ensoli B., Ivanoff L., Chamberlain M., Petteway S., Ratner L., Gallo R.C., Wong S.F. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science. 1987;237:888–893. [PubMed: 3497453]
  212. Fitch T.A., Chang L.J., Stoltzfus C.M. Avian sarcoma virus gag and env gene structural protein precursors contain a common amino-terminal sequence. Proc. Natl. Acad. Sci. 1984;81:362–366. [PMC free article: PMC344676] [PubMed: 6320182]
  213. Fitzgerald P.M., Springer J.P. Structure and function of retroviral proteases. Annu. Rev. Biophys. Biophys. Chem. 1991;20:299–320. [PubMed: 1651087]
  214. Fletcher T.M. III, Brichacek B., Sharova N., Newman M.A., Stivahtis G., Sharp P.M., Emerman M., Hahn B.H., Stevenson M. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIVSM. EMBO J. 1996;15:6155–6165. [PMC free article: PMC452436] [PubMed: 8947037]
  215. Flower A.M., McHenry C.S. The γ subunit of DNA polymerase III holoenzyme of Escherichia coli is produced by ribosomal frameshifting. Proc. Natl. Acad. Sci. 1990;87:3713–3717. [PMC free article: PMC53973] [PubMed: 2187190]
  216. Flynn G.C., Pohl J., Flocco M.T., Rothman J.E. Peptide-binding specificity of the molecular chaperone BiP. Nature. 1991;353:726–730. [PubMed: 1834945]
  217. Foster J.L., Anderson S.J., Frazier A.L., Garcia J.V. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open. Virology. 1994;201:373–379. [PubMed: 8184546]
  218. Fouchier R.A., Simon J.H., Jaffe A.B., Malim M.H. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 1996;70:8263–8269. [PMC free article: PMC190913] [PubMed: 8970945]
  219. Franchini G., Rusche J.R., O'Keeffe T.J., Wong-Staal F. The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virions. AIDS Res. Hum. Retroviruses. 1988;4:243–250. [PubMed: 3061415]
  220. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 1994;372:359–362. [PubMed: 7969494]
  221. Freed E.O., Martin M.A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 1995;69:1984–1989. [PMC free article: PMC188822] [PubMed: 7853546]
  222. Freed E.O., Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 1996;70:341–351. [PMC free article: PMC189823] [PubMed: 8523546]
  223. Freed E.O., Myers D.J., Risser R. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. J. Virol. 1989;63:4670–4675. [PMC free article: PMC251101] [PubMed: 2677400]
  224. Freed E.O., Orenstein J.M., Buckler-White A.J., Martin M.A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block particle formation. J. Virol. 1994;68:5311–5320. [PMC free article: PMC236481] [PubMed: 8035531]
  225. Freund J., Kellner R., Konvalinka J., Wolber V., Kräusslich H.G., Kalbitzer H.R. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur. J. Biochem. 1994;223:589–593. [PubMed: 8055930]
  226. Friborg J., Ladha A., Göttlinger H., Haseltine W.A., Cohen E.A. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 1995;8:10–22. [PubMed: 8548340]
  227. Fu W., Rein A. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 1993;67:5443–5449. [PMC free article: PMC237946] [PubMed: 8350405]
  228. Fu W., Gorelick R.J., Rein A. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J. Virol. 1994;68:5013–5018. [PMC free article: PMC236443] [PubMed: 8035501]
  229. Fu W., Ortiz-Conde B.A., Gorelick R.J., Hughes S.H., Rein A. Placement of tRNA primer on the primer-binding site requires pol gene expression in avian, but not murine retroviruses. J. Virol. (in press). 1997 [PMC free article: PMC191978] [PubMed: 9261422]
  230. Fu X.D., Katz R.A., Skalka A.M., Leis J. Site-directed mutagenesis of the avian retrovirus nucleocapsid protein, pp 12. Mutation which affects RNA binding in vitro blocks viral replication. J. Biol. Chem. 1988;263:2140–2145. [PubMed: 2828360]
  231. Gabuzda D.H., Lawrence K., Langhoff E., Terwilliger E., Dorfman T., Haseltine W.A., Sodroski J. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 1992;66:6489–6495. [PMC free article: PMC240141] [PubMed: 1357189]
  232. Gallagher P.J., Henneberry J.M., Sambrook J.F., Gething M.J. Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus. J. Virol. 1992;66:7136–7145. [PMC free article: PMC240399] [PubMed: 1331514]
  233. Gallaher W.R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell. 1987;50:327–328. [PubMed: 3496970]
  234. Gallaher W.R., Ball J.M., Garry R.F., Griffin M.C., Montelaro R.C. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses. 1989;5:431–440. [PubMed: 2788443]
  235. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 1995a;80:379–388. [PubMed: 7859280]
  236. Gallay P., Stitt V., Mund C., Oettinger M., Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 1996;70:1027–1032. [PMC free article: PMC189908] [PubMed: 8551560]
  237. Gallay P., Swingler S., Song J., Bushman F., Trono D. HIV nuclear import is governed by the phosphotryosine-mediated binding of matrix to the core domain of integrase. Cell. 1995b;83:569–576. [PubMed: 7585960]
  238. Gallina A., Mantoan G., Rindi G., Milanesi G. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein. Biochem. Biophys. Res. Commun. 1994;204:1031–1038. [PubMed: 7980574]
  239. Gallis B., Linial M., Eisenman R.N. An avian oncovirus mutant deficient in genomic RNA: Characterization of the packaged RNA as cellular messenger RNA. Virology. 1979;94:146–161. [PubMed: 220781]
  240. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 1996;87:1285–1294. [PubMed: 8980234]
  241. Garcia J.V., Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 1991;350:508–511. [PubMed: 2014052]
  242. Garcia J.V., Alfano J., Miller A.D. The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J. Virol. 1993;67:1511–1516. [PMC free article: PMC237521] [PubMed: 8437228]
  243. Garnier L., Wills J.W., Verderame M.F., Sudol M. WW domains and retrovirus budding. Nature. 1996;381:744–745. [PubMed: 8657277]
  244. Gebhardt A., Bosch J.V., Ziemiecki A., Friis R.R. Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. An insight into virus assembly. J. Mol. Biol. 1984;174:297–317. [PubMed: 6325711]
  245. Geigenmuller U., Linial M.L. Specific binding of human immunodeficiency virus type 1 (HIV-1) gag-derived proteins to a 5′ HIV-1 genomic RNA sequence. J. Virol. 1996;70:667–671. [PMC free article: PMC189864] [PubMed: 8523591]
  246. Gelderblom H. 1990Morphogenesis, maturation and fine structure of lentiviruses In Retroviral proteases: Maturation and morphogenesis (ed. L.H. Pearl), 159–180. Stockton Press, New York.
  247. Gelderblom H.R., Ozel M., Pauli G. Morphogenesis and morphology of HIV. Structure-function relations. Arch. Virol. 1989;106:1–13. [PubMed: 2669684]
  248. Gelderblom H.R., Hausmann E.H., Ozel M., Pauli G., Koch M.A. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology. 1987;156:171–176. [PubMed: 3643678]
  249. Gelinas C., Temin H.M. Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc. Natl. Acad. Sci. 1986;83:9211–9215. [PMC free article: PMC387105] [PubMed: 3024171]
  250. Geraghty R.J., Panganiban A.T. Human immunodeficiency virus type 1 Vpu has a CD4– and an envelope glycoprotein-independent function. J. Virol. 1993;67:4190–4194. [PMC free article: PMC237788] [PubMed: 8510220]
  251. Geraghty R.J., Talbot K.J., Callahan M., Harper W., Panganiban A.T. Cell type-dependence for Vpu function. J. Med. Primatol. 1994;23:146–150. [PubMed: 7966229]
  252. Gething M.J., Sambrook J. Transport and assembly processes in the endoplasmic reticulum. Semin. Cell Biol. 1990;1:65–72. [PubMed: 1983272]
  253. Gething M.J., McCammon K., Sambrook J. Expression of wild-type and mutant forms of influenza hemagglutinin: The role of folding in intracellular transport. Cell. 1986;46:939–950. [PubMed: 3757030]
  254. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., De Wilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 1989;59:103–112. [PubMed: 2676191]
  255. Gibbs J.S., Regier D.A., Desrosiers R.C. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses. 1994;10:607–616. [PubMed: 7917522]
  256. Gilbert J.M., Bates P., Varmus H.E., White J.M. The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J. Virol. 1994;68:5623–5628. [PMC free article: PMC236963] [PubMed: 8057442]
  257. Gilbert J.M., Hernandez L.D., Chernov-Rogan T., White J.M. Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein. J. Virol. 1993;67:6889–6892. [PMC free article: PMC238138] [PubMed: 7692089]
  258. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 1996;273:231–235. [PubMed: 8662505]
  259. Goff S.P., Lobel L.I. Mutants of murine leukemia viruses and retroviral replication. Biochim. Biophys. Acta. 1987;907:93–123. [PubMed: 3036230]
  260. Goncalves J., Jallepalli P., Gabuzda D.H. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J. Virol. 1994;68:704–712. [PMC free article: PMC236506] [PubMed: 8289374]
  261. Goncalves J., Shi B., Yang X., Gabuzda D. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. J. Virol. 1995;69:7196–7204. [PMC free article: PMC189641] [PubMed: 7474141]
  262. Gonzalez S.A., Affranchino J.L., Gelderblom H.R., Burny A. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology. 1993;194:548–556. [PubMed: 8503172]
  263. Gorelick R.J., Henderson L.E., Hanser J.P., Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: Evidence for specific RNA recognition by a “zinc finger-like” protein sequence. Proc. Natl. Acad. Sci. 1988;85:8420–8424. [PMC free article: PMC282469] [PubMed: 3141927]
  264. Gorelick R.J., Chabot D.J., Rein A., Henderson L.E., Arthur L.O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 1993;67:4027–4036. [PMC free article: PMC237770] [PubMed: 8510214]
  265. Gorelick R.J., Nigida S.M.J., Bess J.W.J., Arthur L.O., Henderson L.E., Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 1990;64:3207–3211. [PMC free article: PMC249531] [PubMed: 2191147]
  266. Gorelick R.J., Chabot D.J., Ott D.E., Gagliardi T.D., Rein A., Henderson L.E., Arthur L.O. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: Replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 1996;70:2593–2597. [PMC free article: PMC190107] [PubMed: 8642691]
  267. Goto T., Ikuta K., Zhang J.J., Morita C., Sano K., Komatsu M., Fujita H., Kato S., Nakai M. The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1. Arch. Virol. 1990;111:87–101. [PubMed: 1691624]
  268. Göttlinger H.G., Sodroski J.G., Haseltine W.A. Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. 1989;86:5781–5785. [PMC free article: PMC297714] [PubMed: 2788277]
  269. Göttlinger H.G., Dorfman T., Cohen E.A., Haseltine W.A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. 1993;90:7381–7385. [PMC free article: PMC47141] [PubMed: 8346259]
  270. Göttlinger H.G., Dorfman T., Sodroski J.G., Haseltine W.A. Effect of mutations affecting the p6 Gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. 1991;88:3195–3199. [PMC free article: PMC51412] [PubMed: 2014240]
  271. Gowda S.D., Stein B.S., Engleman E.G. Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus. J. Biol. Chem. 1989;264:8459–8462. [PubMed: 2785991]
  272. Granowitz C., Goff S.P. Substitution mutations affecting a small region of the Moloney murine leukemia virus MA Gag protein block assembly and release of virion particles. Virology. 1994;205:336–344. [PubMed: 7975229]
  273. Green N., Shinnick T.M., Witte O., Ponticelli A., Sutcliffe J.G., Lerner R.A. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. 1981;78:6023–6027. [PMC free article: PMC348969] [PubMed: 6947213]
  274. Griffiths J.T., Phylip L.H., Konvalinka J., Strop P., Gustchina A., Wlodawer A., Davenport R.J., Briggs R., Dunn B.M., Kay J. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites. Biochemistry. 1992;31:5193–5200. [PubMed: 1606143]
  275. Grinde B., Cameron C.E., Leis J., Weber I.T., Wlodawer A., Burstein H., Skalka A.M. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. J. Biol. Chem. 1992a;267:9491–9498. [PubMed: 1315756]
  276. Grinde B., Cameron C.E., Leis J., Weber I.T., Wlodawer A., Burstein H., Bizub D., Skalka A.M. Mutations that alter the activity of the Rous sarcoma virus protease. J. Biol. Chem. 1992b;267:9481–9490. [PubMed: 1315755]
  277. Gu M., Rappaport J., Leppla S.H. Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett. 1995;365:95–97. [PubMed: 7774724]
  278. Gustchina A., Weber I.T. Comparison of inhibitor binding in HIV-1 protease and in nonviral aspartic proteases: The role of the flap. FEBS Lett. 1990;269:269–272. [PubMed: 2201571]
  279. Gustchina A., Kervinen J., Powell D.J., Zdanov A., Kay J., Wlodawer A. Structure of equine infectious anemia virus proteinase complexed with an inhibitor. Protein Sci. 1996;5:1453–1465. [PMC free article: PMC2143478] [PubMed: 8844837]
  280. Guy B., Geist M., Dott K., Spehner D., Kieny M.P., Lecocq J.P. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J. Virol. 1991;65:1325–1331. [PMC free article: PMC239908] [PubMed: 1995946]
  281. Guy B., Kieny M.P., Riviere Y., Le P.C., Dott K., Girard M., Montagnier L., Lecocq J.P. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature. 1987;330:266–269. [PubMed: 3118220]
  282. Guyader M., Emerman M., Sonigo P., Clavel F., Montagnier L., Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 1987;326:662–669. [PubMed: 3031510]
  283. Haas I.G. BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum. Experientia. 1994;50:1012–1020. [PubMed: 7988659]
  284. Hackett P.B., Dalton M.W., Johnson D.P., Petersen R.B. Phylogenetic and physical analysis of the 5′ leader RNA sequences of avian retroviruses. Nucleic Acids Res. 1991;19:6929–6934. [PMC free article: PMC329330] [PubMed: 1662367]
  285. Hackett P.B., Swanstrom R., Varmus H.E., Bishop J.M. The leader sequence of the subgenomic mRNAs of Rous sarcoma virus is approximately 390 nucleotides. J. Virol. 1982;41:527–534. [PMC free article: PMC256781] [PubMed: 6281464]
  286. Hackett P.B., Petersen R.B., Hensel C.H., Albericio R., Gunderson S.I., Palmenberg A.C., Barany G. Synthesis in vitro of a seven amino acid peptide encoded in the leader RNA of Rous sarcoma virus. J. Mol. Biol. 1986;190:45–57. [PubMed: 3023636]
  287. Hajjar A.M., Linial M.L. A model system for nonhomologous recombination between retroviral and cellular RNA. J. Virol. 1993;67:3845–3853. [PMC free article: PMC237749] [PubMed: 7685401]
  288. Hallenberger S., Tucker S.P., Owens R.J., Bernstein H.B., Compans R.W. Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein. Virology. 1993;193:510–514. [PubMed: 8438588]
  289. Hallenberger S., Bosch V., Angliker H., Shaw E., Klenk H.D., Garten W. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature. 1992;360:358–361. [PubMed: 1360148]
  290. Hammond C., Helenius A. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 1995;7:523–529. [PubMed: 7495572]
  291. Hansen L.J., Chalker D.L., Sandmeyer S.B. Ty3, a yeast retrotransposon associated with tRNA genes, has homology to animal retroviruses. Mol. Cell. Biol. 1988;8:5245–5256. [PMC free article: PMC365627] [PubMed: 2854194]
  292. Hansen M., Jelinek L., Whiting S., Barklis E. Transport and assembly of Gag proteins into Moloney murine leukemia virus. J. Virol. 1990;64:5306–5316. [PMC free article: PMC248579] [PubMed: 1698996]
  293. Harrison G.P., Lever A.M. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 1992;66:4144–4153. [PMC free article: PMC241217] [PubMed: 1602537]
  294. Harrison G.P., Hunter E., Lever A.M. Secondary structure model of the Mason-Pfizer monkey virus 5′ leader sequence: Identification of a structural motif common to a variety of retroviruses. J. Virol. 1995;69:2175–2186. [PMC free article: PMC188886] [PubMed: 7884866]
  295. Hartl F.U., Hlodan R., Langer T. Molecular chaperones in protein folding: The art of avoiding sticky situations. Trends Biochem. Sci. 1994;19:20–25. [PubMed: 7908149]
  296. Haseltine W.A., Panet A., Smoler D., Baltimore D., Peters G., Harada F., Dahlberg J.E. Ineraction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: Further characterization of the binding reaction. Biochemistry. 1977;16:3625–3632. [PubMed: 70221]
  297. Hatanaka M., Nam S.H. Identification of HTLV-I gag protease and its sequential processing of the gag gene product. J Cell Biochem. 1989;40:15–30. [PubMed: 2663887]
  298. Hatfield D.L., Levin J.G., Rein A., Oroszlan S. Translational suppression in retroviral gene expression. Adv. Virus Res. 1992;41:193–239. [PMC free article: PMC7131785] [PubMed: 1575083]
  299. Hayashi T., Ueno Y., Okamoto T. Elucidation of a conserved RNA stem-loop structure in the packaging signal of human immunodeficiency virus type 1. FEBS Lett. 1993;327:213–218. [PubMed: 8335111]
  300. Hayman M.J. Viral polyproteins in chick embryo fibroblasts infected with avian sarcoma leukosis viruses. Virology. 1978;85:241–252. [PubMed: 77076]
  301. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 1995;69:6705–6711. [PMC free article: PMC189580] [PubMed: 7474080]
  302. Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. 1994;91:7311–7315. [PMC free article: PMC44389] [PubMed: 8041786]
  303. Helseth E., Olshevsky U., Furman C., Sodroski J. Human immunodeficiency virus type 1 gp120 regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 1991;65:2119–2123. [PMC free article: PMC240081] [PubMed: 2002555]
  304. Henderson L.E., Krutzsch H.C., Oroszlan S. Myristyl amino-terminal acylation of murine retrovirus proteins: An unusual posttranslational protein modification. Proc. Natl. Acad. Sci. 1983;80:339–343. [PMC free article: PMC393372] [PubMed: 6340098]
  305. Henderson L.E., Sowder R.C., Smythers G.W., Oroszlan S. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins. J. Virol. 1987;61:1116–1124. [PMC free article: PMC254072] [PubMed: 3029406]
  306. Henderson L.E., Sowder R.C., Copeland T.D., Benveniste R.E., Oroszlan S. Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science. 1988a;241:199–201. [PubMed: 3388031]
  307. Henderson L.E., Sowder R., Copeland T.D., Smythers G., Oroszlan S. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 1984;52:492–500. [PMC free article: PMC254550] [PubMed: 6333515]
  308. Henderson L.E., Benveniste R.E., Sowder R., Copeland T.D., Schultz A.M., Oroszlan S. Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J. Virol. 1988b;62:2587–2595. [PMC free article: PMC253688] [PubMed: 3292789]
  309. Herman S.A., Coffin J.M. Efficient packaging of readthrough RNA in ALV: Implications for oncogene transduction. Science. 1987;236:845–848. [PubMed: 3033828]
  310. Heus H.A., Pardi A. Structural features that give rise to the unusual stability of RNA hairpins containing GNRA loops. Science. 1991;253:191–194. [PubMed: 1712983]
  311. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., Sundquist W.I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly. Proc. Natl. Acad. Sci. 1996;93:3099–3104. [PMC free article: PMC39768] [PubMed: 8610175]
  312. Hinnebusch A.G. Evidence for translational regulation of the activator of general amino acid control in yeast. Proc. Natl. Acad. Sci. 1984;81:6442–6446. [PMC free article: PMC391940] [PubMed: 6387704]
  313. Hirsch R.C., Lavine J.E., Chang L.J., Varmus H.E., Ganem D. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature. 1990;344:552–555. [PubMed: 1690862]
  314. Hirschberg C.B., Snider M.D. Topography of glycosylation in the rough endoplasmic reticulum and Golgi apparatus. Annu. Rev. Biochem. 1987;56:63–87. [PubMed: 3304145]
  315. Hizi A., Henderson L.E., Copeland T.D., Sowder R.C., Hixson C.V., Oroszlan S. Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing. Proc. Natl. Acad. Sci. 1987;84:7041–7045. [PMC free article: PMC299225] [PubMed: 2823251]
  316. Hizi A., Henderson L.E., Copeland T.D., Sowder R.C., Krutzsch H.C., Oroszlan S. Analysis of gag proteins from mouse mammary tumor virus. J. Virol. 1989;63:2543–254. [PMC free article: PMC250722] [PubMed: 2542570]
  317. Höglund S., Ohagen A., Lawrence K., Gabuzda D. Role of vif during packing of the core of HIV-1. Virology. 1994;201:349–355. [PubMed: 8184544]
  318. Höglund S., Ohagen A., Goncalves J., Panganiban A.T., Gabuzda D. Ultrastructure of HIV-1 genomic RNA. Virology. 1997;233:271–279. [PubMed: 9217051]
  319. Höglund S., Ofverstedt L.G., Nilsson A., Lundquist P., Gelderblom H., Ozel M., Skoglund U. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res. Hum. Retroviruses. 1992;8:1–7. [PubMed: 1736937]
  320. Hong S.S., Boulanger P. Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells. J. Virol. 1993;67:2787–2798. [PMC free article: PMC237603] [PubMed: 8474175]
  321. Honigman A., Wolf D., Yaish S., Falk H., Panet A. cis acting RNA sequences control the gag-pol translation readthrough in murine leukemia virus. Virology. 1991;183:313–319. [PMC free article: PMC7131665] [PubMed: 2053284]
  322. Horton R., Spearman P., Ratner L. HIV-2 viral protein X association with the GAG p27 capsid protein. Virology. 1994;199:453–457. [PubMed: 8122374]
  323. Hoshikawa N., Kojima A., Yasuda A., Masuko S., Chiba J., Sata T., Kurata T. Role of the gag and pol genes of human immunodeficieny virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: An ultrastructural study. J. Gen. Virol. 1991;72:2509–2517. [PubMed: 1919528]
  324. Hosur M.V., Bhat T.N., Kempf D.J., Baldwin E.T., Liu B., Gulnik S., Wideburg N.E., Norbeck D.W., Appelt K., Erickson J.W. Influence of steriochemistry on activity and binding modes for C2 symmetry-based diol inhibitors of HIV-1 protease. J. Am. Chem. Soc. 1994;116:847–855.
  325. Housset V., De Rocquigny H., Roques B.P., Darlix J.L. Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity. J. Virol. 1993;67:2537–2545. [PMC free article: PMC237573] [PubMed: 8474159]
  326. Hu Y.W., Kang C.Y. Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products. Proc. Natl. Acad. Sci. 1991;88:4596–4600. [PMC free article: PMC51712] [PubMed: 1711203]
  327. Huang M., Martin M.A. Incorporation of Pr160gag-pol into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein. J. Virol. 1997;71:4472–4478. [PMC free article: PMC191666] [PubMed: 9151838]
  328. Huang M., Orenstein J.M., Martin M.A., Freed E.O. P6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 1995;69:6810–6818. [PMC free article: PMC189593] [PubMed: 7474093]
  329. Hughson F.M. Structural characterization of viral fusion proteins (review). Curr. Biol. 1995;5:265–274. [PubMed: 7780737]
  330. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 1994;5:71–83.
  331. Hunter E., Hill E., Hardwick M., Bhown A., Schwartz D.E., Tizard R. Complete sequence of the Rous sarcoma virus env gene: Identification of structural and functional regions of its product. J. Virol. 1983;46:920–936. [PMC free article: PMC256567] [PubMed: 6304351]
  332. Hyland L.J., Tomaszek T.A. Jr., Meek T.D. Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. Biochemistry. 1991a;30:8454–8463. [PubMed: 1883831]
  333. Hyland L.J., Tomaszek T.A. Jr., Roberts G.D., Carr S.A., Magaard V.W., Bryan H.L., Fakhoury S.A., Moore M.L., Minnich M.D., Culp J.S., DesJarlais R.L., Meek T.D. Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 180 isotope exchange. Biochemistry. 1991b;30:8441–8453. [PubMed: 1883830]
  334. Ido E., Han H.P., Kezdy F.J., Tang J. Kinetic studies of human immunodeficiency virus type 1 protease and its active-site hydrogen bond mutant A28S. J. Biol. Chem. 1991;266:24359–24366. [PubMed: 1761538]
  335. Ikawa Y., Ross J., Leder P. An association between globin messenger RNA and 60S RNA derived from Friend leukemia virus. Proc. Natl. Acad. Sci. 1974;71:1154–1158. [PMC free article: PMC388182] [PubMed: 4524626]
  336. Ivey-Hoyle M., Clark R.K., Rosenberg M. The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site. J. Virol. 1991;65:2682–2685. [PMC free article: PMC240627] [PubMed: 2016774]
  337. Jabbar M.A. The human immunodeficiency virus type 1 Vpu protein: Roles in virus release and CD4 downregulation. Curr. Top. Microbiol. Immunol. 1995;193:107–120. [PubMed: 7648871]
  338. Jabbar M.A., Nayak D.P. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J. Virol. 1990;64:6297–6304. [PMC free article: PMC248809] [PubMed: 2243395]
  339. Jacks T. Translational suppression in gene expression in retroviruses and retrotransposons. Curr. Top. Microbiol. Immunol. 1990;157:93–124. [PubMed: 2168307]
  340. Jacks T., Varmus H.E. Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science. 1985;230:1237–1242. [PubMed: 2416054]
  341. Jacks T., Madhani H.D., Masiarz F.R., Varmus H.E. Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell. 1988a;55:447–458. [PMC free article: PMC7133365] [PubMed: 2846182]
  342. Jacks T., Townsley K., Varmus H.E., Majors J. Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins. Proc. Natl. Acad. Sci. 1987;84:4298–4302. [PMC free article: PMC305072] [PubMed: 3035577]
  343. Jacks T., Power M.D., Masiarz F.R., Luciw P.A., Barr P.J., Varmus H.E. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature. 1988b;331:280–283. [PubMed: 2447506]
  344. Jacobsen H., Ahlborn L.L., Gugel R., Mous J. Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease. J. Virol. 1992;66:5087–5091. [PMC free article: PMC241373] [PubMed: 1378515]
  345. Jamjoom G.A., Naso R.B., Arlinghaus R.B. Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J. Virol. 1976;19:1054–1072. [PMC free article: PMC354946] [PubMed: 1085824]
  346. Jamjoom G.A., Naso R.B., Arlinghaus R.B. Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus. Virology. 1977;78:11–34. [PubMed: 67705]
  347. Jiang M., Mak J., Ladha A., Cohen E., Klein M., Rovinski B., Kleiman L. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 1993;67:3246–3253. [PMC free article: PMC237665] [PubMed: 8497049]
  348. Johnston P.B., Dubay J.W., Hunter E. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 1993;67:3077–3086. [PMC free article: PMC237644] [PubMed: 8497044]
  349. Jones D.S., Nemoto F., Kuchino Y., Masuda M., Yoshikura H., Nishimura S. The effect of specific mutations at and around the gag-pol gene junction of Moloney murine leukaemia virus. Nucleic Acids Res. 1989;17:5933–5945. [PMC free article: PMC318251] [PubMed: 2549503]
  350. Jones T.A., Blaug G., Hansen M., Barklis E. Assembly of Gag-β-galactosidase proteins into retrovirus particles. J. Virol. 1990;64:2265–2279. [PMC free article: PMC249388] [PubMed: 2109101]
  351. JØrgensen E.C., Pedersen F.S., JØrgensen P. Matrix protein of Akv murine leukemia virus: Genetic mapping of regions essential for particle formation. J. Virol. 1992;66:4479–4487. [PMC free article: PMC241257] [PubMed: 1318415]
  352. Jowett J.B., Hockley D.J., Nermut M.V., Jones I.M. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. J. Gen. Virol. 1992;73:3079–3086. [PubMed: 1469349]
  353. Jowett J.B., Planelles V., Poon B., Shah N.P., Chen M.L., Chen I.S. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 1995;69:6304–6313. [PMC free article: PMC189529] [PubMed: 7666531]
  354. Kageyama S., Hoekzema D.T., Murakawa Y., Kojima E., Shirasaka T., Kempf D.J., Norbeck D.W., Erickson J., Mitsuya H. A C2 symmetry-based human immunodeficiency virus protease inhibitor, A77003, irreversibly inhibits infectivity of human immunodeficiency virus type 1 in vitro. AIDS Res. Hum. Retroviruses. 1994;10:735–743. [PubMed: 8074936]
  355. Kan N.C., Franchini G., Wong S.F., DuBois G.C., Robey W.G., Lautenberger J.A., Papas T.S. Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera. Science. 1986;231:1553–1555. [PubMed: 3006245]
  356. Kaplan A.H., Swanstrom R. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. 1991;88:4528–4532. [PMC free article: PMC51694] [PubMed: 2034693]
  357. Kaplan A.H., Manchester M., Swanstrom R. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 1994a;68:6782–6786. [PMC free article: PMC237104] [PubMed: 8084015]
  358. Kaplan A.H., Krogstad P., Kempf D.J., Norbeck D.W., Swanstrom R. Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA. Antimicrob. Agents Chemother. 1994b;38:2929–2933. [PMC free article: PMC188311] [PubMed: 7695287]
  359. Kaplan A.H., Manchester M., Smith T., Yang Y.L., Swanstrom R. Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication. J. Virol. 1996;70:5840–5844. [PMC free article: PMC190600] [PubMed: 8709202]
  360. Kaplan A.H., Zack J.A., Knigge M., Paul D.A., Kempf D.J., Norbeck D.W., Swanstrom R. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 1993;67:4050–4055. [PMC free article: PMC237772] [PubMed: 8510215]
  361. Kappes J.C., Parkin J.S., Conway J.A., Kim J., Brouillette C.G., Shaw G.M., Hahn B.H. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology. 1993;193:222–233. [PubMed: 8438567]
  362. Kappes J.C., Morrow C.D., Lee S.W., Jameson B.A., Kent S.B., Hood L.E., Shaw G.M., Hahn B.H. Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. J. Virol. 1988;62:3501–3505. [PMC free article: PMC253477] [PubMed: 3136256]
  363. Karacostas V., Wolffe E.J., Nagashima K., Gonda M.A., Moss B. Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology. 1993;193:661–671. [PubMed: 7681610]
  364. Karczewski M.K., Strebel K. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 1996;70:494–507. [PMC free article: PMC189838] [PubMed: 8523563]
  365. Karpel R.L., Henderson L.E., Oroszlan S. Interactions of retroviral structural proteins with single-stranded nucleic acids. J. Biol. Chem. 1987;262:4961–4967. [PubMed: 2435721]
  366. Katoh I., Yasunaga T., Yoshinaka Y. Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: Close relation to the packaging sites of avian, murine, and human retroviruses. J. Virol. 1993;67:1830–1839. [PMC free article: PMC240239] [PubMed: 8383213]
  367. Katoh I., Yasunaga T., Ikawa Y., Yoshinaka Y. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature. 1987;329:654–656. [PubMed: 2821409]
  368. Katoh I., Kyushiki H., Sakamoto Y., Ikawa Y., Yoshinaka Y. Bovine leukemia virus matrix-associated protein MA(p15): Further processing and formation of a specific complex with the dimer of the 5′-terminal genomic RNA fragment. J. Virol. 1991;65:6845–6855. [PMC free article: PMC250779] [PubMed: 1658378]
  369. Katoh I., Yoshinaka Y., Rein A., Shibuya M., Odaka T., Oroszlan S. Murine leukemia virus maturation: Protease region required for conversion from “immature” to “mature” core form and for virus infectivity. Virology. 1985;145:280–292. [PubMed: 2411050]
  370. Katsumoto T., Asanaka M., Kageyama S., Kurimura T., Nakajima K., Noto A., Tanaka H., Sato R. Budding process and maturation of human immunodeficiency virus examined by means of pre- and post-embedding immunocolloidal gold electron microscopy. J. Electron Microsc. 1990;39:33–38. [PubMed: 2358770]
  371. Katz R.A., Skalka A.M. The retroviral enzymes. Annu. Rev. Biochem. 1994;63:133–173. [PubMed: 7526778]
  372. Katz R.A., Terry R.W., Skalka A.M. A conserved cis-acting sequence in the 5′ leader of avian sarcoma virus RNA is required for packaging. J. Virol. 1986;59:163–167. [PMC free article: PMC253052] [PubMed: 3012114]
  373. Kawai S., Koyoma and T. Cahracterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: Biological properties of mutant TK15 and mutant-induced transformants. J. Virol. 1984;51:147–153. [PMC free article: PMC254412] [PubMed: 6328034]
  374. Kempf D.J., Marsh K.C., Denissen J.F., McDonald E., Vasavanonda S., Flentge C.A., Green B.E., Fino L., Park C.H., Kong X.P., Wideburg N.E., Saldivar A., Ruiz L., Kati W.M., Sham H.L., Robins T., Stewart K.D., Hsu A., Plattner J.J., Leonard J.M., Norbeck D.W. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc. Natl. Acad. Sci. 1995;92:2484–2488. [PMC free article: PMC42242] [PubMed: 7708670]
  375. Khan R., Giedroc D.P. Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 1992;267:6689–6695. [PubMed: 1551877]
  376. Khan R., Giedroc D.P. Nucleic acid binding properties of recombinant Zn2 HIV-1 nucleocapsid protein are modulated by COOH-terminal processing. J. Biol. Chem. 1994;269:22538–22546. [PubMed: 8077202]
  377. Kim H.J., Lee K., O'Rear J.J. A short sequence upstream of the 5′ major splice site is important for encapsidation of human immunodeficiency virus type 1 genomic RNA. Virology. 1994;198:336–340. [PubMed: 8259668]
  378. Kim J., Mosior M., Chung L.A., Wu H., McLaughlin S. Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys. J. 1991;60:135–148. [PMC free article: PMC1260045] [PubMed: 1883932]
  379. Klikova M., Rhee S.S., Hunter E., Ruml T. Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria. J. Virol. 1995;69:1093–1098. [PMC free article: PMC188681] [PubMed: 7815488]
  380. Klimkait T., Strebel K., Hoggan M.D., Martin M.A., Orenstein J.M. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 1990;64:621–629. [PMC free article: PMC249152] [PubMed: 2404139]
  381. Knight J.B., Si Z.H., Stoltzfus C.M. A base-paired structure in the avian sarcoma virus 5′ leader is required for efficient encapsidation of RNA. J. Virol. 1994;68:4493–4502. [PMC free article: PMC236375] [PubMed: 8207823]
  382. Kohl N.E., Emini E.A., Schleif W.A., Davis L.J., Heimbach J.C., Dixon R.A., Scolnick E.M., Sigal I.S. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. 1988;85:4686–4690. [PMC free article: PMC280500] [PubMed: 3290901]
  383. Kollmus H., Honigman A., Panet A., Hauser H. The sequences of and distance between two cis-acting signals determine the efficiency of ribosomal frameshifting in human immunodeficiency virus type 1 and human T-cell leukemia virus type II in vivo. J. Virol. 1994;68:6087–6091. [PMC free article: PMC237019] [PubMed: 8057488]
  384. Kondo E., Göttlinger H.G. A conserved LXXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency viurs type 1 vpr. J. Virol. 1996;70:159–164. [PMC free article: PMC189800] [PubMed: 8523520]
  385. Kondo E., Mammano F., Cohen E., Göttlinger H. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous virus particles. J. Virol. 1995;69:2759–2764. [PMC free article: PMC188969] [PubMed: 7707498]
  386. Konings D.A., Nash M.A., Maizel J.V., Arlinghaus R.B. Novel GACG-hairpin pair motif in the 5′ untranslated region of type C retroviruses related to murine leukemia virus. J. Virol. 1992;66:632–640. [PMC free article: PMC240761] [PubMed: 1309906]
  387. Konvalinka J., Lochelt M., Zentgraf H., Flugel R.M., Kräusslich H.G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J. Virol. 1995a;69:7264–7268. [PMC free article: PMC189650] [PubMed: 7474150]
  388. Konvalinka J., Heuser A.M., Hruskova H.O., Vogt V.M., Sedlacek J., Strop P., Kräusslich H.G. Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases. Eur. J. Biochem. 1995b;228:191–198. [PubMed: 7883003]
  389. Konvalinka J., Litterst M.A., Welker R., Kottler H., Rippmann F., Heuser A.M., Kräusslich H.G. An active-site mutation in the human immunodeficiency virus type 1 proteinase PR causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 1995c;69:7180–7186. [PMC free article: PMC189639] [PubMed: 7474139]
  390. Konvalinka J., Blaha I., Skrabana R., Sedlacek J., Pichova I., Kapralek F., Kostka V., Strop P. Subsite specificity of the proteinase from myeloblastosis associated virus. FEBS Lett. 1991;282:73–76. [PubMed: 2026269]
  391. Konvalinka J., Horejsi M., Andreansky M., Novek P., Pichova I., Blaha I., Fabry M., Sedlacek J., Foundling S., Strop P. An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase. EMBO J. 1992;11:1141–1144. [PMC free article: PMC556556] [PubMed: 1547777]
  392. Korb J., Travnicek M., Riman J. The oncornavirus maturation process: Quantitative correlation between morphological changes and conversion of genomic virion RNA. Intervirology. 1976;7:211–224. [PubMed: 188781]
  393. Kotler M., Arad G., Hughes S.H. Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active. J. Virol. 1992;66:6781–6783. [PMC free article: PMC240177] [PubMed: 1404618]
  394. Kotler M., Danho W., Katz R.A., Leis J., Skalka A.M. Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates. J. Biol. Chem. 1989;264:3428–3435. [PubMed: 2536748]
  395. Kotler M., Katz R.A., Danho W., Leis J., Skalka A.M. Synthetic peptides as substrates and inhibitors of a retroviral protease. Proc. Natl. Acad. Sci. 1988;85:4185–4189. [PMC free article: PMC280391] [PubMed: 2837759]
  396. Koyama T., Harada F., Kawai S. Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: Biochemical properties of mutant TK15 and mutant-induced transformants. J. Virol. 1984;51:154–162. [PMC free article: PMC254413] [PubMed: 6202881]
  397. Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. 1986;83:2850–2854. [PMC free article: PMC323404] [PubMed: 3458245]
  398. Kozak M. The scanning model for translation: An update. J. Cell. Biol. 1989;108:229–241. [PMC free article: PMC2115416] [PubMed: 2645293]
  399. Kozak M. A consideration of alterative models for the initiation of translation in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 1992;27:385–402. [PubMed: 1521462]
  400. Kramer R.A., Schaber M.D., Skalka A.M., Ganguly K., Wong S.F., Reddy E.P. HTLV-III gag protein is processed in yeast cells by the virus pol-protease. Science. 1986;231:1580–1584. [PubMed: 2420008]
  401. Kräusslich H.G. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. 1991;88:3213–3217. [PMC free article: PMC51416] [PubMed: 2014242]
  402. Kräusslich H.D., Welker R. Intracellular transport of retroviral capsid components. Curr. Top. Microbiol. Immunol. 1996;214:25–63. [PubMed: 8791724]
  403. Kräusslich H., Fäcke M., Heuser A., Konvalinka J., Hanswalter Z. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 1995;69:3407–3419. [PMC free article: PMC189053] [PubMed: 7745687]
  404. Kräusslich H.G., Schneider H., Zybarth G., Carter C.A., Wimmer E. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J. Virol. 1988;62:4393–4397. [PMC free article: PMC253881] [PubMed: 3050149]
  405. Kräusslich H.G., Ingraham R.H., Skoog M.T., Wimmer E., Pallai P.V., Carter C.A. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc. Natl. Acad. Sci. 1989;86:807–811. [PMC free article: PMC286566] [PubMed: 2644644]
  406. Krishna N.K., Weldon R.A., Wills J.W. Targeting and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum. J. Virol. 1996;70:1570–1579. [PMC free article: PMC189979] [PubMed: 8627676]
  407. Kuff E.L., Lueders K.K. The intracisternal A-particle gene family: Structure and functional aspects. Adv. Cancer Res. 1988;51:183–276. [PubMed: 3146900]
  408. Kung H.J., Hu S., Bender W., Bailey J.M., Davidson N. RD-114, baboon, woolly monkey viral RNAs compared in size and structure. Cell. 1976;7:609–620. [PubMed: 182377]
  409. Lapadat-Tapolsky M., De Rocquigny H., Van Gent D., Roques B., Plasterk R., Darlix J.L. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 1993;21:831–839. [PMC free article: PMC309214] [PubMed: 8383840]
  410. Lapatto R., Blundell T., Hemmings A., Overington J., Wilderspin A., Wood S., Merson J.R., Whittle P.J., Danley D.E., Geoghegan K.F., Hawrylik S.J., Lee S.E., Scheld K.G., Hobart P.M. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes. Nature. 1989;342:299–302. [PubMed: 2682266]
  411. Laughrea M., Jette L. A 19-nucleotide sequence upstream of the 5′ major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry. 1994;33:13464–13474. [PubMed: 7947755]
  412. Laughrea M., Jette L., Mak J., Kleiman L., Liang C., Wainberg M.A. Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization. J. Virol. 1997;71:3397–3406. [PMC free article: PMC191484] [PubMed: 9094609]
  413. Lavallee C., Yao X.J., Ladha A., Gottlinger H., Haseltine W.A., Cohen E.A. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J. Virol. 1994;68:1926–1934. [PMC free article: PMC236654] [PubMed: 8107252]
  414. Le S.Y., Chen J.H., Maizel J.V. Thermodynamic stability and statistical significance of potential stem-loop structures situated at the frameshift sites of retroviruses. Nucleic Acids Res. 1989;17:6143–6152. [PMC free article: PMC318267] [PubMed: 2549508]
  415. Leamnson R.N., Halpern M.S. Subunit structure of the glycoprotein complex of avian tumor virus. J. Virol. 1976;18:956–968. [PMC free article: PMC354796] [PubMed: 178931]
  416. Leamnson R.N., Shander M.H.M., Halpern M.S. A structural protein complex in Moloney leukemia virus. Virology. 1977;76:437–439. [PubMed: 835238]
  417. Ledbetter J.A. Two-dimensional analysis of murine leukemia virus gag-gene polyproteins. Virology. 1979;95:85–98. [PubMed: 442546]
  418. Lee P.P., Linial M.L. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J. Virol. 1994;68:6644–6654. [PMC free article: PMC237085] [PubMed: 7521919]
  419. Lee T.H., Coligan J.E., Allan J.S., McLane M.F., Groopman J.E., Essex M. A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science. 1986;231:1546–1549. [PubMed: 3006243]
  420. Lee Y.M., Tang X.B., Cimakasky L.M., Hildreth J.E., Yu X.F. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes. J. Virol. 1997;71:1443–1452. [PMC free article: PMC191201] [PubMed: 8995670]
  421. Le Grice S.F., Beuck V., Mous J. Expression of biologically active human T-cell lymphotropic virus type III reverse transcriptase in Bacillus subtilis. Gene. 1987;55:95–103. [PubMed: 2442069]
  422. Le Grice S.F., Mills J., Mous J. Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J. 1988;7:2547–2553. [PMC free article: PMC457126] [PubMed: 2461297]
  423. Lenburg M.E., Landau N.R. Vpu-induced degradation of CD4: Requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 1993;67:7238–7245. [PMC free article: PMC238186] [PubMed: 8230446]
  424. Lever A., Göttlinger H., Haseltine W., Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 1989;63:4085–4087. [PMC free article: PMC251012] [PubMed: 2760989]
  425. Levin J.G., Rosenak M.J. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: Evidence for persistence of viral messenger RNA. Proc. Natl. Acad. Sci. 1976;4:1154–1158. [PMC free article: PMC430219] [PubMed: 57617]
  426. Levin J.G., Seidman J.G. Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA. J. Virol. 1979;29:328–335. [PMC free article: PMC353124] [PubMed: 219227]
  427. Levin J.G., Seidman J.G. Effect of polymerase mutations on packaging of primer tRNApro during murine leukemia virus assembly. J. Virol. 1981;38:403–408. [PMC free article: PMC171167] [PubMed: 6165833]
  428. Levin J.G., Grimley P.M., Ramseur J.M., Berezesky I.K. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 1974;14:152–161. [PMC free article: PMC355489] [PubMed: 4134468]
  429. Levin J.G., Hatfield D.L., Oroszlan S., Rein A. 1993Mechanisms of translational suppression used in the biosynthesis of reverse transcriptase In Reverse transcriptase (ed. A.M. Skalka and S.P. Goff), pp. 5–31. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
  430. Levin J.G., Hu S.C., Rein A., Messer L.I., Gerwin B.I. Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: Implications for pol gene structure. J. Virol. 1984;51:470–478. [PMC free article: PMC254461] [PubMed: 6205170]
  431. Levy D.N., Refaeli Y., Weiner D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 1995;69:1243–1252. [PMC free article: PMC188697] [PubMed: 7815499]
  432. Levy D.N., Fernandes L.S., Williams W.V., Weiner D.B. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell. 1993;72:541–550. [PubMed: 8440020]
  433. Lillehoj E.P., Salazar F.H., Mervis R.J., Raum M.G., Chan H.W., Ahmad N., Venkatesan S. Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus. J. Virol. 1988;62:3053–3058. [PMC free article: PMC253749] [PubMed: 3292793]
  434. Lindhofer H., von der Helm K., Nitschko H. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes. Virology. 1995;214:624–627. [PubMed: 8553565]
  435. Linial M.L., Miller A.D. Retroviral RNA packaging: Sequence requirements and implications. Curr. Top. Microbiol. Immunol. 1990;157:125–152. [PubMed: 2394131]
  436. Linial M., Medeiros E., Hayward W.S. An avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: Biological and biochemical characterization. Cell. 1978;15:1371–1381. [PubMed: 83199]
  437. Lippincott-Schwartz J., Yuan L.C., Bonifacino J.S., Klausner R.D. Rapid redistribution of Golgi proteins into the ER in cells treated wih brefeldin A: Evidence for membrane cycling from Golgi to ER. Cell. 1989;56:801–813. [PMC free article: PMC7173269] [PubMed: 2647301]
  438. Liu H., Wu X., Newman M., Shaw G.M., Hahn B.H., Kappes J.C. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 1995;69:7630–7638. [PMC free article: PMC189703] [PubMed: 7494271]
  439. Lobel L.I., Goff S.P. Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertional mutagenesis: Positions of viable insertion mutations. Proc. Natl. Acad. Sci. 1984;81:4149–4153. [PMC free article: PMC345386] [PubMed: 6330745]
  440. Lodge R., Göttlinger H., Gabuzda D., Cohen E.A., Lemay G. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 1994;68:4857–4861. [PMC free article: PMC236425] [PubMed: 8035484]
  441. Loeb D.D., Hutchison C.A. III, Edgell M.H., Farmerie W.G., Swanstrom R. Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases. J. Virol. 1989a;63:111–121. [PMC free article: PMC247663] [PubMed: 2642305]
  442. Loeb D.D., Swanstrom R., Everitt L., Manchester M., Stamper S.E., Hutchison C.A. III. Complete mutagenesis of the HIV-1 protease. Nature. 1989b;340:397–400. [PubMed: 2666861]
  443. Lori F., Scovassi A.I., Zella D., Achilli G., Cattaneo E., Casoli C., Bertazzoni U. Enzymatically active forms of reverse transcriptase of the human immunodeficiency virus. AIDS Res. Hum. Retroviruses. 1988;4:393–398. [PubMed: 2461725]
  444. Louis J.M., Nashed N.T., Parris K.D., Kimmel A.R., Jerina D.M. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein. Proc. Natl. Acad. Sci. 1994;91:7970–7974. [PMC free article: PMC44526] [PubMed: 8058744]
  445. Louis J.M., Smith C.A., Wondrak E.M., Mora P.T., Oroszlan S. Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activity. Biochem. Biophys. Res. Commun. 1989;164:30–38. [PubMed: 2679552]
  446. Louis J.M., McDonald R.A., Nashed N.T., Wondrak E.M., Jerina D.M., Oroszlan S., Mora P.T. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli. Eur. J. Biochem. 1991;199:361–369. [PubMed: 2070793]
  447. Lu Y.L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 1993;67:6542–6550. [PMC free article: PMC238091] [PubMed: 8411357]
  448. Lu Y.L., Bennett R.P., Wills J.W., Gorelick R., Ratner L. A leucine triplet repeat sequence (LXX) 4 in p6gag is important for vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 1995;69:7630–7638. [PMC free article: PMC189602] [PubMed: 7474102]
  449. Luban J., Goff S.P. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J. Virol. 1991;65:3203–3212. [PMC free article: PMC240977] [PubMed: 2033671]
  450. Luban J., Goff S.P. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J. Virol. 1994;68:3784–3793. [PMC free article: PMC236883] [PubMed: 8189516]
  451. Luban J., Alin K.B., Bossolt K.L., Humaran T., Goff S.P. Genetic assay for multimerization of retroviral Gag polyproteins. J. Virol. 1992;66:5157–5160. [PMC free article: PMC241396] [PubMed: 1629970]
  452. Lund A.H., Duch M., Lovmand J., Jorgensen P., Pedersen F.S. Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J. Virol. 1993;67:7125–7130. [PMC free article: PMC238174] [PubMed: 7693968]
  453. Lutcke H. Signal recognition particle (SRP), a ubiquitous initiator of protein translocation. Eur. J. Biochem. 1995;228:531–550. [PubMed: 7737147]
  454. Mador N., Panet A., Honigman A. Translation of gag, pro, and pol gene products of human T-cell leukemia virus type 2. J. Virol. 1989;63:2400–2404. [PMC free article: PMC250667] [PubMed: 2467996]
  455. Mahalingam S., Collman R.G., Patel M., Monken C.E., Srinivasan A. Functional analysis of human immunodeficiency virus type 1 Vpr: Identification of determinants essential for subcellular localization. Virology. 1995a;212:331–339. [PubMed: 7571402]
  456. Mahalingam S., Khan S.A., Murali R., Jabbar M.A., Monken C.E., Collman R.G., Srinivasan A. Mutagenesis of the putative α-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation. Proc. Natl. Acad. Sci. 1995b;92:3794–3798. [PMC free article: PMC42048] [PubMed: 7731985]
  457. Mak J., Jiang M., Wainberg M.A., Hammarskjold M.L., Rekosh D., Kleiman L. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J. Virol. 1994;68:2065–2072. [PMC free article: PMC236680] [PubMed: 7511167]
  458. Maldarelli F., Chen M.Y., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 1993;67:5056–5061. [PMC free article: PMC237897] [PubMed: 8331740]
  459. Mammano F., Ohagen A., Höglund S., Göttlinger H.G. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 1994;68:4927–4936. [PMC free article: PMC236433] [PubMed: 8035491]
  460. Mammano F., Kondo E., Sodroski J., Bukovsky A., Göttlinger H.G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 1995;69:3824–3830. [PMC free article: PMC189100] [PubMed: 7745730]
  461. Mann R., Baltimore D. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J. Virol. 1985;54:401–407. [PMC free article: PMC254810] [PubMed: 3989912]
  462. Mann R., Mulligan R.C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 1983;33:153–159. [PubMed: 6678608]
  463. Mansky L., Krueger A., Temin H. The bovine leukemia virus endapsidation signal is discontinuous and extends into the 5′ end of the gag gene. J. Virol. 1995;69:3282–3289. [PMC free article: PMC189039] [PubMed: 7745675]
  464. Margolin N., Heath W., Osborne E., Lai M., Vlahos C. Substitutions at the P2′ site of gag p17-p24 affect cleavage efficiency by HIV-1 protease. Biochem. Biophys. Res. Commun. 1990;167:554–560. [PubMed: 2182016]
  465. Massey R.J., Schochetman G. Gene order of mouse mammary tumor virus precursor polyproteins and their interaction leading to the formation of a virus. Virology. 1979;99:358–371. [PubMed: 229627]
  466. Massiah M.A., Starich M.R., Paschall C., Summers M.F., Christensen A.M., Sundquist W.I. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 1994;244:198–223. [PubMed: 7966331]
  467. Matano T., Odawara T., Ohshima M., Yoshikura H., Iwamoto A. trans-dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus. J. Virol. 1993;67:2026–2033. [PMC free article: PMC240271] [PubMed: 8445721]
  468. Matter K., Mellman I. Mechanisms of cell polarity: Sorting and transport in epithelial cells. Curr. Opin. Cell Biol. 1994;6:545–554. [PubMed: 7986532]
  469. Matthews S., Barlow P., Boyd J., Russell R., Mills H., Cunningham M., Meyers N., Burns N.C., Kingsman A., Campbell I. Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ Nature. 1994;370:666–668. [PubMed: 8065455]
  470. Maurer B., Bannert H., Darai G., Flugel R.M. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 1988;62:1590–1597. [PMC free article: PMC253186] [PubMed: 2451755]
  471. Maxwell S., Arlinghaus R.B. In vitro proteolytic cleavage of Gazdar murine sarcoma virus p65gag. J. Virol. 1981;39:963–967. [PMC free article: PMC171332] [PubMed: 6169847]
  472. McBride M.S., Panganiban A.T. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 1996;70:2963–2973. [PMC free article: PMC190155] [PubMed: 8627772]
  473. McBride M.S., Panganiban A.T. Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. J. Virol. 1997;71:2050–2058. [PMC free article: PMC191293] [PubMed: 9032337]
  474. McBride M.S., Schwartz M.D., Panganiban A.T. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation. J. Virol. 1997;71:4544–4554. [PMC free article: PMC191676] [PubMed: 9151848]
  475. McClure M.O., Sommerfelt M.A., Marsh M., Weiss R.A. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 1990;71:767–773. [PubMed: 2157795]
  476. McLaughlin S., Aderem A. The myristoyl-electrostatic switch: A modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 1995;20:272–276. [PubMed: 7667880]
  477. McQuade T.J., Tomasselli A.G., Liu L., Karacostas V., Moss B., Sawyer T.K., Heinrikson R.L., Tarpley W.G. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science. 1990;247:454–456. [PubMed: 2405486]
  478. Meek T.D., Dayton B.D., Metcalf B.W., Dreyer G.B., Strickler J.E., Gorniak J.G., Rosenberg M., Moore M.L., Magaard V.W., Debouck C. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. Proc. Natl. Acad. Sci. 1989;86:1841–1845. [PMC free article: PMC286800] [PubMed: 2648384]
  479. Meek T.D., Lambert D.M., Dreyer G.B., Carr T.J., Tomaszek T.A.J., Moore M.L., Strickler J.E., Debouck C., Hyland L.J., Matthews T.J., Metcalf B.W., Petteway S.R. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature. 1990;343:90–92. [PubMed: 1688646]
  480. Menendez-Arias L., Risco C., Pinto da Silva P., Oroszlan S. Purification of immature cores of mouse mammary tumor virus and immunolocalization of protein domains. J. Virol. 1992;66:5615–5620. [PMC free article: PMC289125] [PubMed: 1380097]
  481. Méric C., Goff S.P. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 1989;63:1558–1568. [PMC free article: PMC248388] [PubMed: 2926863]
  482. Méric C., Spahr P.F. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 1986;60:450–459. [PMC free article: PMC288912] [PubMed: 2430109]
  483. Méric C., Gouilloud E., Spahr P.F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): Deletions of Cys-His boxes. J. Virol. 1988;62:3328–3333. [PMC free article: PMC253454] [PubMed: 2841485]
  484. Mervis R.J., Ahmad N., Lillehoj E.P., Raum M.G., Salazar F.H., Chan H.W., Venkatesan S. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 1988;62:3993–4002. [PMC free article: PMC253827] [PubMed: 3262776]
  485. Messer L., Levin J., Chattopadhyay S.K. Metabolism of viral RNA in murine leukemia virus-infected cells: Evidence for differential stability of viral message and virion precursor RNA. J. Virol. 1981;40:683–690. [PMC free article: PMC256680] [PubMed: 6172599]
  486. Michaels F.H., Hattori N., Gallo R.C., Franchini G. The human immunodeficiency virus type 1 (HIV-1) Vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. AIDS Res. Hum. Retroviruses. 1993;9:1025–1030. [PubMed: 8280477]
  487. Mietz J.A., Grossman Z., Lueders K.K., Kuff E.L. Nucleotide sequence of a complete mouse intracisternal A-particle genome: Relationship to known aspects of particle assembly and function. J. Virol. 1987;61:3020–3029. [PMC free article: PMC255875] [PubMed: 3041022]
  488. Miller M., Jaskolski M., Rao J.K., Leis J., Wlodawer A. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature. 1989a;337:576–579. [PubMed: 2536902]
  489. Miller M.D., Warmerdam M.T., Page K.A., Feinberg M.B., Greene W.C. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 1995;69:579–584. [PMC free article: PMC188614] [PubMed: 7983759]
  490. Miller M., Schneider J., Sathyanarayana B.K., Toth M.V., Marshall G.R., Clawson L., Selk L., Kent S.B., Wlodawer A. Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution. Science. 1989b;246:1149–1152. [PubMed: 2686029]
  491. Mizuno A., Ido E., Goto T., Kuwata T., Nakai M., Hayami M. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: Effects on proteolytic processing of Gag precursors and particle formation. AIDS Res. Hum. Retroviruses. 1996;12:793–800. [PubMed: 8738431]
  492. Moody M.D., Pettit S.C., Shao W., Everitt L., Loeb D.D., Hutchison C.A. III, Swanstrom R. A side chain at position 48 of the human immonodeficiency virus type-1 protease flap provides an additional specificity determinant. Virology. 1995;207:475–485. [PubMed: 7886951]
  493. Moore M.L., Bryan W.M., Fakhoury S.A., Magaard V.W., Huffman W.F., Dayton B.D., Meek T.D., Hyland L., Dreyer G.B., Metcalf B.W., Strickler J.E., Gorniak J.G., Debouck C. Peptide substrates and inhibitors of the HIV-1 protease. Biochem. Biophys. Res. Commun. 1989;159:420–425. [PubMed: 2649094]
  494. Moore R., Dixon M., Smith R., Peters G., Dickson C. Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: Two frameshift suppression events are required for translation of gag and pol. J. Virol. 1987;61:480–490. [PMC free article: PMC253972] [PubMed: 3027377]
  495. Morikawa S., Bishop D.H. Identification and analysis of the gag-pol ribosomal frameshift site of feline immunodeficiency virus. Virology. 1992;186:389–397. [PMC free article: PMC7131530] [PubMed: 1310175]
  496. Morikawa Y., Barsov E., Jones I. Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin. J. Virol. 1993;67:3601–3604. [PMC free article: PMC237708] [PubMed: 8497067]
  497. Morikawa Y., Hinata S., Tomoda H., Goto T., Nakai M., Aizawa C., Tanaka H., Omura S. Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J. Biol. Chem. 1996;271:2868–2873. [PubMed: 8576268]
  498. Mosior M., McLaughlin S. Binding of basic peptides to acidic lipids in membranes: Effects of inserting alanine(s) between the basic residues. Biochemistry. 1992;31:1767–1773. [PubMed: 1737030]
  499. Mougel M., Tounekti N., Darlix J.L., Paoletti J., Ehresmann B., Ehresmann C. Conformational analysis of the 5′ leader and the gag initiation site of Mo-MuLV RNA and allosteric transitions induced by dimerization. Nucleic Acids Res. 1993;21:4677–4684. [PMC free article: PMC331490] [PubMed: 8233816]
  500. Mous J., Heimer E.P., Le Grice S.F. Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli. J. Virol. 1988;62:1433–1436. [PMC free article: PMC253157] [PubMed: 2450209]
  501. Moustakas A., Sonstegard T.S., Hackett P.B. Alterations of the three short open reading frames in the Rous sarcoma virus leader RNA modulate viral replication and gene expression. J. Virol. 1993a;67:4337–4349. [PMC free article: PMC237804] [PubMed: 7685415]
  502. Moustakas A., Sonstegard T.S., Hackett P.B. Effects of the open reading frames in the Rous sarcoma virus leader RNA on translation. J. Virol. 1993b;67:4350–4357. [PMC free article: PMC237805] [PubMed: 8389931]
  503. Mueller P.P., Hinnebusch A.G. Multiple upstream AUG codons mediate translational control of GCN4. Cell. 1986;45:201–207. [PubMed: 3516411]
  504. Mulichak A.M., Hui J.O., Tomasselli A.G., Heinrikson R.L., Curry K.A., Tomich C.S., Thaisrivongs S., Sawyer T.K., Watenpaugh K.D. The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. J. Biol. Chem. 1993;268:13103–13109. [PubMed: 8514751]
  505. Murphy J.E., Goff S.P. Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: Effects on RNA packaging and reverse transcription. J. Virol. 1989;63:319–327. [PMC free article: PMC247687] [PubMed: 2908924]
  506. Murti K.G., Bondurant M., Tereba A. Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy. J. Virol. 1981;37:411–419. [PMC free article: PMC171018] [PubMed: 6260992]
  507. Mustafa F., Robinson H.L. Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers. J. Virol. 1993;67:6909–6915. [PMC free article: PMC238142] [PubMed: 8411397]
  508. Myers G., Korber B., Pavlakis G.N., Jeang K.T., Henderson L.E., Wain-Hobson S. 1994A compilation and analysis of nucleic acid and amino acid sequences In Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, New Mexico.
  509. Nagy K., Young M., Baboonian C., Merson J., Whittle P., Oroszlan S. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: Evidence for a role of protease in the early phase. J. Virol. 1994;68:757–765. [PMC free article: PMC236512] [PubMed: 8289379]
  510. Nam S.H., Copeland T.D., Hatanaka M., Oroszlan S. Characterization of ribosomal frameshifting for expression of pol gene products of human T-cell leukemia virus type I. J. Virol. 1993;67:196–203. [PMC free article: PMC237352] [PubMed: 8416368]
  511. Nam S.H., Kidokoro M., Shida H., Hatanaka M. Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease. J. Virol. 1988;62:3718–3728. [PMC free article: PMC253515] [PubMed: 2843670]
  512. Naso R.B., Karshin W.L., Arlinghaus R.B. Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products. J. Virol. 1979;32:187–198. [PMC free article: PMC353542] [PubMed: 94357]
  513. Nassal M., Junker-Niepmann M., Schaller H. Translational inactivation of RNA function: Discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell. 1990;63:1357–1363. [PubMed: 2261646]
  514. Navia M.A., Fitzgerald P.M., McKeever B.M., Leu C.T., Heimbach J.C., Herber W.K., Sigal I.S., Darke P.L., Springer J.P. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature. 1989;337:615–620. [PubMed: 2645523]
  515. Nelle T.D., Wills J.W. A large region within the Rous sarcome virus matrix protein dispensable for budding and infectivity. J. Virol. 1996;70:2269–2276. [PMC free article: PMC190068] [PubMed: 8642653]
  516. Nikbakht K.N., Ou C.Y., Boone L.R., Glover P.L., Yang W.K. Nucleotide sequence analysis of endogenous murine leukemia virus-related proviral clones reveals primer-binding sites for glutamine tRNA. J. Virol. 1985;54:889–893. [PMC free article: PMC254883] [PubMed: 2987543]
  517. Nishizawa M., Koyama T., Kawai S. Unusual features of the leader sequence of Rous sarcoma virus packaging mutant TK15. J. Virol. 1985;55:881–885. [PMC free article: PMC255081] [PubMed: 2991609]
  518. Nishizawa M., Koyama T., Kawai S. Frequent segregation of more-defective variants from a Rous sarcoma virus packaging mutant, TK15. J. Virol. 1987;61:3208–3213. [PMC free article: PMC255899] [PubMed: 3041042]
  519. Noiva R. Enzymatic catalysis of disulfide formation. Protein Expr. Purif. 1994;5:1–13. [PubMed: 7909462]
  520. Norton P.A., Coffin J.M. Bacterial β-galactosidase as a marker of Rous sarcoma virus gene expression and replication. Mol. Cell. Biol. 1985;5:281–290. [PMC free article: PMC366710] [PubMed: 2983187]
  521. Novella I., Santiago F., Moya A., Domingo E., Holland J. Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J. Virol. 1995;69:2869–2072. [PMC free article: PMC188983] [PubMed: 7707510]
  522. Oberste M.S., Gonda M.A. Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes. 1992;6:95–102. [PubMed: 1312756]
  523. Oertle S., Spahr P.F. Role of the gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA. J. Virol. 1990;64:5757–5763. [PMC free article: PMC248723] [PubMed: 1700822]
  524. Ohnishi Y., Shioda T., Nakayama K., Iwata S., Gotoh B., Hamaguchi M., Nagai Y. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J. Virol. 1994;68:4075–4079. [PMC free article: PMC236921] [PubMed: 8189547]
  525. Ono M., Toh H., Miyata T., Awaya T. Nucleotide sequence of the Syrian hamster intracisternal A-particle gene: Close evolutionary relationship of type A particle gene to types B and D oncovirus genes. J. Virol. 1985;55:387–394. [PMC free article: PMC254945] [PubMed: 2991563]
  526. Op den Kamp J.A.F. Lipid asymmetry of membranes. Annu. Rev. Biochem. 1979;48:47–71. [PubMed: 382989]
  527. Oppermann H., Bishop J.M., Varmus H.E., Levintow L. A joint product of the genes gag and pol of avian sarcoma virus: A possible precursor of reverse transcriptase. Cell. 1977;12:993–1005. [PubMed: 74287]
  528. Orlinsky K.J., Gu J., Hoyt M., Sandmeyer S.B., Menees T.M. Mutations in the Ty3 major homology region affect multiple steps in Ty3 retrotransposition. J. Virol. 1996;70:3440–3448. [PMC free article: PMC190217] [PubMed: 8648676]
  529. Oroszlan S., Copeland T.D. Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK. Curr. Top. Microbiol. Immunol. 1985;115:221–233. [PubMed: 2983943]
  530. Oroszlan S., Luftig R.B. Retroviral proteinases. Curr. Top. Microbiol. Immunol. 1990;157:153–185. [PubMed: 2203608]
  531. Ott D.E., Coren L.V., Kane B.P., Busch L.K., Johnson D.G., Sowder II R.C., Chertova E.N., Arthur L.O., Henderson L.E. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 1996;70:7734–7743. [PMC free article: PMC190843] [PubMed: 8892894]
  532. Otteken A., Moss B. Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. J. Biol. Chem. 1996;271:97–103. [PubMed: 8550632]
  533. Ottmann M., Gabus C., Darlix J.L. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 1995;69:1778–1784. [PMC free article: PMC188785] [PubMed: 7853517]
  534. Owens R.J., Compans R.W. Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J. Virol. 1989;63:978–982. [PMC free article: PMC247779] [PubMed: 2536121]
  535. Owens R.J., Compans R.W. The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. Virology. 1990;179:827–833. [PubMed: 2238472]
  536. Owens R.J., Dubay J.W., Hunter E., Compans R.W. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl. Acad. Sci. 1991;88:3987–3991. [PMC free article: PMC51578] [PubMed: 2023946]
  537. Ozols J., Carr S.A., Strittmatter P. Identification of the NH2-terminal blocking group of NADH-cytochrome b5 reductase as myristic acid and the complete amino acid sequence of the membrane-binding domain. J. Biol. Chem. 1984;259:13349–13354. [PubMed: 6436247]
  538. Paillart J.-C., Berthoux L., Ottmann M., Darlix J.-L., Marquet R., Ehresmann B., Ehresmann C. A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis. J. Virol. 1996;70:8348–8354. [PMC free article: PMC190922] [PubMed: 8970954]
  539. Pal R., Mumbauer S., Hoke G.M., Takatsuki A., Sarngadharan M.G. Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 1991;7:707–712. [PubMed: 1718346]
  540. Palmer E., Sporborg C., Harrison A., Martin M.L., Feorino P. Morphology and immunoelectron microscopy of AIDS virus. Arch. Virol. 1985;85:189–196. [PubMed: 2992418]
  541. Palmiter R.D., Gagnon J., Vogt V.M., Ripley S., Eisenman R.N. The NH2-terminal sequence of the avian oncovirus gag precursor polyprotein (Pr76gag). Virology. 1978;91:423–433. [PubMed: 217156]
  542. Pandori M.W., Fitch N.J., Craig H.M., Richman D.D., Spina C.A., Guatelli J.C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 1996;70:4283–4289. [PMC free article: PMC190360] [PubMed: 8676450]
  543. Panet A., Baltimore D. Characterization of endonuclease activities in Moloney murine leukemia virus and its replication-defective mutants. J. Virol. 1987;61:1756–1760. [PMC free article: PMC254172] [PubMed: 3033306]
  544. Panet A., Berliner H. Binding of tRNA to reverse transcriptase of RNA tumor viruses. J. Virol. 1978;26:214–220. [PMC free article: PMC354057] [PubMed: 77907]
  545. Panet A., Haseltine W.A., Baltimore D., Peters G., Harada F., Dahlberg J.E. Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase). Proc. Natl. Acad. Sci. 1975;72:2535–2539. [PMC free article: PMC432803] [PubMed: 52156]
  546. Panganiban A.T. Retroviral gag gene amber codon suppression is caused by an intrinsic cis-acting component of the viral mRNA. J. Virol. 1988;62:3574–3580. [PMC free article: PMC253496] [PubMed: 2843660]
  547. Parent L.J., Wilson C.B., Resh M.D., Wills J.W. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J. Virol. 1996;70:1016–1026. [PMC free article: PMC189907] [PubMed: 8551559]
  548. Parent L.J., Bennett R.P., Craven R.C., Nelle T.D., Krishna N.K., Bowzard J.B., Wilson C.B., Puffer B.A., Montelaro R.C., Wills J.W. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 1995;69:5455–5460. [PMC free article: PMC189393] [PubMed: 7636991]
  549. Park J., Morrow C.D. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J. Virol. 1991;65:5111–5117. [PMC free article: PMC248980] [PubMed: 1870215]
  550. Park J., Morrow C.D. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. J. Virol. 1992;66:6304–6313. [PMC free article: PMC240122] [PubMed: 1383561]
  551. Park J., Morrow C.D. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles. Virology. 1993;194:843–850. [PubMed: 8503189]
  552. Parkin N.T., Chamorro M., Varmus H.E. Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: Demonstration by expression in vivo. J. Virol. 1992;66:5147–5151. [PMC free article: PMC241392] [PubMed: 1321294]
  553. Parolin C., Dorfman T., Palu G., Gottlinger H., Sodroski J. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 1994;68:3888–3895. [PMC free article: PMC236894] [PubMed: 7910642]
  554. Partin K., Kräusslich H.G., Ehrlich L., Wimmer E., Carter C. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase. J. Virol. 1990;64:3938–3947. [PMC free article: PMC249689] [PubMed: 2196384]
  555. Partin K., Zybarth G., Ehrlich L., DeCrombrugghe M., Wimmer E., Carter C. Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. 1991;88:4776–4780. [PMC free article: PMC51749] [PubMed: 1647017]
  556. Patarca R., Haseltine W.A. A major retroviral core protein related to EPA and TIMP. Nature. 1985;318:390. [PubMed: 3877876]
  557. Patick A.K., Mo H., Markowitz M., Appelt K., Wu B., Misick L., Kalish V., Kaldor S., Reich S., Ho D., Webber S. Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. Antimicrob. Agents Chemother. 1996;40:292–297. [PMC free article: PMC163104] [PubMed: 8834868]
  558. Paxton W., Connor R.I., Landau N.R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 1993;67:7229–7237. [PMC free article: PMC238185] [PubMed: 8230445]
  559. Pearce-Pratt R., Malamud D., Phillips D.M. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J. Virol. 1994;68:2898–2905. [PMC free article: PMC236778] [PubMed: 8151760]
  560. Pearl L.H., Taylor W.R. A structural model for the retroviral proteases. Nature. 1987;329:351–354. [PubMed: 3306411]
  561. Peitzsch R.M., McLaughlin S. Binding of acylated peptides and fatty acids to phospholipid vesicles: Pertinence to myristoylated proteins. Biochemistry. 1993;32:10436–10443. [PubMed: 8399188]
  562. Pelham H.R. Multiple targets for brefeldin A. Cell. 1991;67:449–451. [PubMed: 1934055]
  563. Peng C., Chang N.T., Chang T.W. Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells. J. Virol. 1991;65:2751–2756. [PMC free article: PMC240643] [PubMed: 1707986]
  564. Peng C., Ho B.K., Chang T.W., Chang N.T. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J. Virol. 1989;63:2550–2556. [PMC free article: PMC250724] [PubMed: 2657099]
  565. Pepinsky R.B. Localization of lipid-protein and protein-protein interactions within the murine retrovirus Gag precursor by a novel peptide-mapping technique. J. Biol. Chem. 1983;258:11229–11235. [PubMed: 6309837]
  566. Pepinsky R.B., Vogt V.M. Identification of retrovirus matrix proteins by lipid-protein crosslinking. J. Mol. Biol. 1979;131:819–837. [PubMed: 229234]
  567. Pepinsky R.B., Vogt V.M. Fine-structure analyses of lipid-protein and protein-protein interactions of Gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping. J. Virol. 1984;52:145–153. [PMC free article: PMC254500] [PubMed: 6090691]
  568. Pepinsky R.B., Mattaliano R.J., Vogt V.M. Structure and processing of the p2 region of avian sarcoma and leukemia virus gag precursor polyproteins. J. Virol. 1986;58:50–58. [PMC free article: PMC252875] [PubMed: 3005658]
  569. Pepinsky R.B., Cappiello D., Wilkowski C., Vogt V.M. Chemical crosslinking of proteins in avian sarcoma and leukemia viruses. Virology. 1980;102:205–210. [PubMed: 6245502]
  570. Perez L.G., Hunter E. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37. J. Virol. 1987;61:1609–1614. [PMC free article: PMC254142] [PubMed: 3033286]
  571. Perez L.G., Davis G.L., Hunter E. Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: Analysis of intracellular transport and assembly into virions. J. Virol. 1987;61:2981–2988. [PMC free article: PMC255870] [PubMed: 3041017]
  572. Peters G., Hu J. Reverse transcriptase as the major determinant for selective packaging of tRNA's into avian sarcoma virus particles. J. Virol. 1980;36:692–700. [PMC free article: PMC353697] [PubMed: 6162035]
  573. Peters G., Harada F., Dahlberg J.E., Panet A., Haseltine W.A., Baltimore D. Low-molecular-weight RNAs of Moloney murine leukemia virus: Identification of the primer for RNA-directed DNA synthesis. J. Virol. 1977;21:1031–1041. [PMC free article: PMC515643] [PubMed: 66325]
  574. Peterson R.B., Moustakas A., Hackett P.B. A mutation in the short 5′-proximal open reading frame on Rous sarcoma virus RNA alters virus production. J. Virol. 1989;63:4787–4796. [PMC free article: PMC251116] [PubMed: 2552153]
  575. Pettit S.C., Michael S.F., Swanstrom R. The specificity of the human immunodeficiency virus type 1 protease. Perspect. Drug Discov. Des. 1993;1:69–83.
  576. Pettit S.C., Simsic J., Loeb D.D., Everitt L., Hutchison C.A. III, Swanstrom R. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 1991;266:14539–14547. [PubMed: 1860860]
  577. Pettit S.C., Moody M.D., Wehbie R.S., Kaplan A.H., Nantermet P.V., Klein C.A., Swanstrom R. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 1994;68:8017–8027. [PMC free article: PMC237265] [PubMed: 7966591]
  578. Philipson L., Andersson P., Olshevsky U., Weinberg R., Baltimore D., Gesteland R. Translation of MuLV and MSV RNAs in nuclease-treated reticulocyte extracts: Enhancement of the gag-pol polypeptide with yeast suppressor tRNA. Cell. 1978;13:189–199. [PubMed: 202399]
  579. Phylip L.H., Mills J.S., Parten B.F., Dunn B.M., Kay J. Intrinsic activity of precursor forms of HIV-1 proteinase. FEBS Lett. 1992;314:449–454. [PubMed: 1468583]
  580. Phylip L.H., Richards A.D., Kay J., Kovalinka J., Strop P., Blaha I., Velek J., Kostka V., Ritchie A.J., Broadhurst A.V., Farmerie W.G., Scarborough P.E., Dunn B.M. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. Biochem. Biophys. Res. Commun. 1990;171:439–444. [PubMed: 2203349]
  581. Pillemer E.A., Kooistra D.A., Witte O.N., Weissman I.L. Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated Gag polyproteins demonstrates their unusual orientation in the cell membrane. J. Virol. 1986;57:413–421. [PMC free article: PMC252752] [PubMed: 2418213]
  582. Pinter A., Honnen W.J. O-linked glycosylation of retroviral envelope gene products. J. Virol. 1988;62:1016–1021. [PMC free article: PMC253661] [PubMed: 2828650]
  583. Pinter A., Honnen W.J., Li J.S. Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of Friend mink cell focus-inducing murine leukemia virus envelope proteins. Virology. 1984;136:196–210. [PubMed: 6330991]
  584. Pinter A., Honnen W.J., Revesz K., Herz R. Identification of large glycosylated proteins recognized by monoclonal antibodies against HIV-1 Gag proteins. AIDS Res. Hum. Retroviruses. 1992;8:1341–1344. [PubMed: 1466953]
  585. Pinter A., Honnen W.J., Tilley S.A., Bona C., Zaghouani H., Gorny M.K., Zolla-Pazner S. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 1989;63:2674–2679. [PMC free article: PMC250755] [PubMed: 2786089]
  586. Pique C., Pham D., Tursz T., Dokhelar M.C. Human T-cell leukemia virus type I envelope protein maturation process: Requirements for syncytium formation. J. Virol. 1992;66:906–913. [PMC free article: PMC240791] [PubMed: 1530980]
  587. Platt E.J., Haffar O.K. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: Requirement for a C-terminal domain. Proc. Natl. Acad. Sci. 1994;91:4594–4598. [PMC free article: PMC43832] [PubMed: 8183954]
  588. Pleij C.W., Rietveld K., Bosch L. A new principle of RNA folding based on pseudoknotting. Nucleic Acids Res. 1985;13:1717–1731. [PMC free article: PMC341107] [PubMed: 4000943]
  589. Poon D.T., Wu J., Aldovini A. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J.Virol. 1996;70:6607–6616. [PMC free article: PMC190701] [PubMed: 8794295]
  590. Poorman R.A., Tomasselli A.G., Heinrikson R.L., Kezdy F.J. A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J. Biol. Chem. 1991;266:14554–14561. [PubMed: 1860861]
  591. Portis J.L., Spangrude G.J., McAtee F.J. Identification of a sequence in the unique 5′ open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus. J. Virol. 1994;68:3879–3887. [PMC free article: PMC236893] [PubMed: 8189525]
  592. Poumbourios P., el Ahmar W., McPhee D.A., Kemp B.E. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol. 1995;69:1209–1218. [PMC free article: PMC188694] [PubMed: 7815497]
  593. Poznansky M., Lever A., Bergeron L., Haseltine W., Sodroski J. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 1991;65:532–536. [PMC free article: PMC240552] [PubMed: 1985215]
  594. Prats A.C., de Billy G., Wang P., Darlix J.-L. CUG initiation codon used for the synthesis of a cell surface antigen coded by murine leukemia virus. J. Mol. Biol. 1989;205:363–372. [PubMed: 2538626]
  595. Prats A.C., Sarih L., Gabus C., Litvak S., Keith G., Darlix J.L. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 1988;7:1777–1783. [PMC free article: PMC457168] [PubMed: 2458920]
  596. Prats A.C., Housset V., de Billy G., Cornille F., Prats H., Roques B., Darlix J.L. Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent. Nucleic Acids Res. 1991;19:3533–3541. [PMC free article: PMC328376] [PubMed: 1906602]
  597. Prats A.C., Roy C., Wang P.A., Erard M., Housset V., Gabus C., Paoletti C., Darlix J.L. cis Elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. J. Virol. 1990;64:774–783. [PMC free article: PMC249172] [PubMed: 2153242]
  598. Quigley J.P., Rifkin D.B., Reich E. Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology. 1971;46:106–116. [PubMed: 4108030]
  599. Rabson A.B., Daugherty D.F., Venkatesan S., Boulukos K.E., Benn S.I., Folks T.M., Feorino P., Martin M.A. Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes. Science. 1985;229:1388–1390. [PubMed: 2994220]
  600. Racevskis J., Sarkar N. Synthesis and processing of precursor polypeptides to murine mammary tumor virus structural proteins. J. Virol. 1978;25:374–383. [PMC free article: PMC353935] [PubMed: 202748]
  601. Ragheb J.A., Anderson W.F. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: Implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 1994;68:3220–3231. [PMC free article: PMC236813] [PubMed: 8151784]
  602. Raja N.U., Vincent M.J., Jabbar M.A. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. J. Gen. Virol. 1993;74:2085–2097. [PubMed: 8409933]
  603. Raja N.U., Vincent M.J., Jabbar M.A. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: Requirement of both the anchor and cytoplasmic domains of CD4. Virology. 1994;204:357–366. [PubMed: 8091666]
  604. Rao J.K., Erickson J.W., Wlodawer A. Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases. Biochemistry. 1991;30:4663–4671. [PubMed: 1851433]
  605. Rao Z., Belyaev A.S., Fry E., Roy P., Jones I.M., Stuart D.I. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature. 1995;378:743–747. [PubMed: 7501025]
  606. Ravichandran K.S., Collins T.L., Burakoff S.J. CD4 and signal transduction. Curr. Top. Microbiol. Immunol. 1996;205:47–62. [PubMed: 8575197]
  607. Re F., Braaten D., Franke E.K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 1995;69:6859–6864. [PMC free article: PMC189600] [PubMed: 7474100]
  608. Reicin A.S., Paik S., Berkowitz R.D., Luban J., Lowy I., Goff S.P. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: Effects on virion particle assembly, release, and infectivity. J. Virol. 1995;69:642–650. [PMC free article: PMC188624] [PubMed: 7815527]
  609. Reil H., Kollmus H., Weidle U.H., Hauser H. A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells. J. Virol. 1993;67:5579–5584. [PMC free article: PMC237961] [PubMed: 8350413]
  610. Rein A. Retroviral RNA packaging: A review. Arch. Virol. Suppl. 1994;9:513–522. [PubMed: 8032280]
  611. Rein A., Harvin D.P., Mirro J., Ernst S.M., Gorelick R.J. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. J. Virol. 1994a;68:6124–6129. [PMC free article: PMC237026] [PubMed: 8057495]
  612. Rein A., McClure M.R., Rice N.R., Luftig R.B., Schultz A.M. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. 1986;83:7246–7250. [PMC free article: PMC386692] [PubMed: 3489936]
  613. Rein A., Mirro J., Haynes J.G., Ernst S.M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 1994b;68:1773–1781. [PMC free article: PMC236638] [PubMed: 8107239]
  614. Renne R., Friedl E., Schweizer M., Fleps U., Turek R., Neumann-Haefelin D. Genomic organization and expression of simian foamy virus type 3 (SFV-3). Virology. 1992;186:597–608. [PubMed: 1310187]
  615. Resh M.D. Interaction of tyrosine kinase oncoproteins with cellular membranes. Biochim. Biophys. Acta. 1993;1155:307–322. [PubMed: 8268189]
  616. Resh M.D. Myristylation and palmitylation of Src family members: The fats of the matter. Cell. 1994;76:411–413. [PubMed: 8313462]
  617. Rey O., Canon J., Krogstad P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology. 1996;220:530–534. [PubMed: 8661406]
  618. Rhee S.S., Hunter E. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol. 1987;61:1045–1053. [PMC free article: PMC254061] [PubMed: 3493352]
  619. Rhee S.S., Hunter E. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell. 1990a;63:77–86. [PubMed: 2170021]
  620. Rhee S.S., Hunter E. Structural role of the matrix protein of type D retroviruses in Gag polyprotein stability and capsid assembly. J. Virol. 1990b;64:4383–4389. [PMC free article: PMC247906] [PubMed: 2200887]
  621. Rhee S.S., Hunter E. Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. EMBO J. 1991;10:535–546. [PMC free article: PMC452681] [PubMed: 1705884]
  622. Rhee S.S., Marsh J.W. Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 1994;68:5156–5163. [PMC free article: PMC236459] [PubMed: 8035515]
  623. Rhee S.S., Hui H., Hunter E. Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specfically to the plasma membrane. J. Virol. 1990;64:3844–3852. [PMC free article: PMC249680] [PubMed: 2370682]
  624. Richards A.D., Roberts R., Dunn B.M., Graves M.C., Kay J. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases. FEBS Lett. 1989;247:113–117. [PubMed: 2651157]
  625. Richards A.D., Phylip L.H., Farmerie W.G., Scarborough P.E., Alvarez A., Dunn B.M., Hirel P.H., Konvalinka J., Strop P., Pavlickova L., Kostka V., Kay J. Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J. Biol. Chem. 1990;265:7733–7736. [PubMed: 2186027]
  626. Richardson J.H., Child L.A., Lever A.M. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5′ leader region. J. Virol. 1993;67:3997–4005. [PMC free article: PMC237767] [PubMed: 8510213]
  627. Ridky T.W., Bizub B.D., Cameron C.E., Weber I.T., Wlodawer A., Copeland T., Skalka A.M., Leis J. Programming the Rous sarcoma virus protease to cleave new substrate sequences. J. Biol. Chem. 1996a;271:10538–10544. [PubMed: 8631853]
  628. Ridky T.W., Cameron C.E., Cameron J., Leis J., Copeland T., Wlodawer A., Weber I.T., Harrison R.W. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites. J. Biol. Chem. 1996b;271:4709–4717. [PubMed: 8617736]
  629. Ringe D. X-ray structures of retroviral proteases and their inhibitor-bound complexes. Methods Enzymol. 1994;241:157–177. [PubMed: 7854176]
  630. Riviere Y., Blank V., Kourilsky P., Israel A. Processing of the precursor of NF-κB by the HIV-1 protease during acute infection. Nature. 1991;350:625–626. [PubMed: 2017258]
  631. Rizvi T.A., Panganiban A.T. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 1993;67:2681–2688. [PMC free article: PMC237590] [PubMed: 8474168]
  632. Roberts M.M., Oroszlan S. The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. Biochem. Biophys. Res. Commun. 1989;160:486–494. [PubMed: 2541703]
  633. Roberts M.M., Copeland T.D., Oroszlan S. In situ processing of a retroviral nucleocapsid protein by the viral proteinase. Protein Eng. 1991;4:695–700. [PubMed: 1658777]
  634. Roberts N.A., Martin J.A., Kinchington D., Broadhurst A.V., Craig J.C., Duncan I.B., Galpin S.A., Handa B.K., Kay J., Krohn A., Lambert R.W., Merrett J.H., Mills J.S., Parkes K.E.B., Redshaw S., Ritchie A.J., Tayor D.L., Thomas G.J., Machin P.J. Rational design of peptide-based HIV proteinase inhibitors. Science. 1990;248:358–361. [PubMed: 2183354]
  635. Rogel M.E., Wu L.I., Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 1995;69:882–888. [PMC free article: PMC188655] [PubMed: 7815556]
  636. Rose J., Babe L., Craik C. Defining the level of human immunofeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J. Virol. 1995;69:2751–2758. [PMC free article: PMC188968] [PubMed: 7535864]
  637. Rose R.B., Rose J.R., Salto R., Craik C.S., Stroud R.M. Structure of the protease from simian immunodeficiency virus: Complex with an irreversible nonpeptide inhibitor. Biochemistry. 1993;32:12498–12507. [PubMed: 8241141]
  638. Roth M.G., Srinivas R.V., Compans R.W. Basolateral maturation of retroviruses in polarized epithelial cells. J. Virol. 1983;45:1065–1073. [PMC free article: PMC256514] [PubMed: 6339737]
  639. Rothman J.E. Polypeptide chain binding proteins: Catalysts of protein folding and related processes in cells. Cell. 1989;59:591–601. [PubMed: 2573430]
  640. Royer M., Cerutti M., Gay B., Hong S.S., Devauchelle G., Boulanger P. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells. Virology. 1991;184:417–422. [PubMed: 1871977]
  641. Sakaguchi K., Zambrano N., Baldwin E.T., Shapiro B.A., Erickson J.W., Omichinski J.G., Clore G.M., Gronenborn A.M., Appella E. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proc. Natl. Acad. Sci. 1993;90:5219–5223. [PMC free article: PMC46687] [PubMed: 8506369]
  642. Sakai H., Tokunaga K., Kawamura M., Adachi A. Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J. Gen. Virol. 1995;76:2717–2722. [PubMed: 7595378]
  643. Sakai H., Shibata R., Sakuragi J., Sakuragi S., Kawamura M., Adachi A. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 1993;67:1663–1666. [PMC free article: PMC237539] [PubMed: 8437236]
  644. Sakalian M., Wills J.W., Vogt V.M. Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. J. Virol. 1994;68:5969–5981. [PMC free article: PMC237002] [PubMed: 8057473]
  645. Sakalian M., Parker S.D., Weldon R.A. Jr., Hunter E. Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro. J. Virol. 1996;70:3706–3715. [PMC free article: PMC190246] [PubMed: 8648705]
  646. Sallafranque-Andreola M.L., Robert D., Barr P.J., Fournier M., Litvak S., Sarih C.L., Tarrago L.L. Human immunodeficiency virus reverse transcriptase expressed in transformed yeast cells. Biochemical properties and interactions with bovine tRNALys. Eur. J. Biochem. 1989;184:367–374. [PubMed: 2477248]
  647. Salzwedel K., Johnston P.B., Roberts S.J., Dubay J.W., Hunter E. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 1993;67:5279–5288. [PMC free article: PMC237926] [PubMed: 8102410]
  648. Sanfridson A., Cullen B.R., Doyle C. The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. J. Biol. Chem. 1994;269:3917–3920. [PubMed: 7905875]
  649. Saraste J., Kuismanen E. Pathways of protein sorting and membrane traffic between the rough endoplasmic reticulum and the Golgi complex. Semin. Cell Biol. 1992;3:343–355. [PMC free article: PMC7128811] [PubMed: 1457777]
  650. Sardana V.V., Schlabach A.J., Graham P., Bush B.L., Condra J.H., Culberson J.C., Gotlib L., Graham D.J., Kohl N.E., LaFemina R.L., Schneider C.L., Wolanski B.S., Wolfgang J.A., Emini E.A. Human immunodeficiency virus type 1 protease inhibitors: Evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site. Biochemistry. 1994;33:2004–2010. [PubMed: 8117657]
  651. Saris C.J.M., van Eenbergen J., Liskamp R.M.J., Bloemers H.P.J. Structure of glycosylated and unglycosylated Gag and Gag-Pol precursor proteins of Moloney murine leukemia virus. J. Virol. 1983;46:841–859. [PMC free article: PMC256560] [PubMed: 6602220]
  652. Sarkar N.H. The effects of 2-deoxyglucose and tunicamycin on the biosynthesis of the murine mammary tumor virus proteins, and on the assembly and release of the virus. Virology. 1986;150:419–438. [PubMed: 3008416]
  653. Sasaki H., Nakamura M., Ohno T., Matsuda Y., Yuda Y., Nonomura Y. Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc. Natl. Acad. Sci. 1995;92:2026–2030. [PMC free article: PMC42416] [PubMed: 7892219]
  654. Sawyer R.C., Hanafusa H. Comparison of the small RNAs of polymerase-deficient and polymerase-positive Rous sarcoma virus and another species of avian retrovirus. J. Virol. 1979;29:863–871. [PMC free article: PMC353245] [PubMed: 87521]
  655. Schätzl H., Gelderblom H.R., Nitschko H., von der Helm K. Analysis of noninfectious HIV particles produced in presence of HIV proteinase inhibitor. Arch. Virol. 1991;120:71–81. [PubMed: 1929879]
  656. Schawaller M., Smith G.E., Skehel J.J., Wiley D.C. Studies with crosslinking reagents on the oligomeric structure of the Env glycoprotein of HIV. Virology. 1989;172:367–369. [PubMed: 2672564]
  657. Schlesinger S., Makino S., Linial M. cis-Acting genomic elements and trans-acting proteins involved in the assembly of RNA viruses. Virology. 1994;5:39–49. [PMC free article: PMC7129795] [PubMed: 32288439]
  658. Schock H.B., Garsky V.M., Kuo L.C. Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity. J. Biol. Chem. 1996;271:31957–31963. [PubMed: 8943242]
  659. Schorr J., Kellner R., Fackler O., Freund J., Konvalinka J., Kienzle N., Kräusslich H.-G., Mueller-Lantzsch N., Kalbitzer H.R. Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases. J. Virol. 1996;70:9051–9054. [PMC free article: PMC191010] [PubMed: 8971042]
  660. Schubert U., Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 1994;68:2260–2271. [PMC free article: PMC236702] [PubMed: 8139011]
  661. Schubert U., Bour S., Ferrer-Montiel A.V., Montal M., Maldarell F., Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 1996;70:809–819. [PMC free article: PMC189883] [PubMed: 8551619]
  662. Schultz A.M., Rein A. Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology. 1985;145:335–339. [PubMed: 2992156]
  663. Schultz A.M., Rein A. Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J. Virol. 1989;63:2370–2373. [PMC free article: PMC250660] [PubMed: 2649693]
  664. Schultz A.M., Henderson L.E., Oroszlan S. Fatty acylation of proteins. Annu. Rev. Cell Biol. 1988;4:611–647. [PubMed: 3058168]
  665. Schwartz D.E., Tizard R., Gilbert W. Nucleotide sequence of Rous sarcoma virus. Cell. 1983;32:853–869. [PubMed: 6299578]
  666. Schwartz O., Marechal V., Danos O., Heard J.M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 1995;69:4053–4059. [PMC free article: PMC189139] [PubMed: 7539505]
  667. Schwartzberg P., Colicelli J., Goff S.P. Deletion mutants of Moloney murine leukemia virus which lack glycosylated Gag protein are replication competent. Virology. 1983;46:538–546. [PMC free article: PMC255156] [PubMed: 6601726]
  668. Schwartzberg P., Colicelli J., Gordon M.L., Goff S.P. Mutations in the gag gene of moloney murine leukemia virus: Effects on production of virions and reverse transcriptase. J. Virol. 1984;49:918–924. [PMC free article: PMC255554] [PubMed: 6199513]
  669. Sedlacek J., Fabry M., Coward J.E., Horejsi M., Strop P., Luftig R.B. Myeloblastosis associated virus (MAV) proteinase site-mutated to be HIV-like has a higher activity and allows production of infectious but morphologically altered virus. Virology. 1993;192:667–672. [PubMed: 7678476]
  670. Seelmeier S., Schmidt H., Turk V., von der Helm K. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc. Natl. Acad. Sci. 1988;85:6612–6616. [PMC free article: PMC282027] [PubMed: 3045820]
  671. Selig L., Benichou S., Rogel M.E., Wu L.I., Vodicka M.A., Sire J., Benarous R., Emerman M. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 1997;71:4842–4846. [PMC free article: PMC191711] [PubMed: 9151883]
  672. Shank P.R., Linial M. Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: Characterization of a deletion in the provirus. J. Virol. 1980;36:450–456. [PMC free article: PMC353661] [PubMed: 6253670]
  673. Shen L.X., Tinoco I. Jr. The structure of an RNA pseudoknot that causes efficient frameshifting in mouse mammary tumor virus. J. Mol. Biol. 1995;247:963–978. [PubMed: 7723043]
  674. Sheng N., Erickson-Viitenan S. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. J. Virol. 1994;68:6207–6214. [PMC free article: PMC237040] [PubMed: 8083960]
  675. Sheng N., Pettit S.C., Tritch R.J., Ozturk D.H., Rayner M.M., Swanstrom R., Erickson-Viitanen S. Determinants of HIV-1 p15NC-RNA interactions that affect enhanced cleavage by protease. J. Virol. 1997;71:5723–5732. [PMC free article: PMC191824] [PubMed: 9223458]
  676. Shields A., Witte O.N., Rothenberg E., Baltimore D. High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell. 1978;14:601–609. [PubMed: 80281]
  677. Shimada T., Fujii H., Mitsuya H., Nienhuis A.W. Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 1991;88:1043–1047. [PMC free article: PMC295518] [PubMed: 1885765]
  678. Shimotohno K., Temin H. Loss of intervening sequences in genomic mouse α-globin DNA inserted in an infectious retrovirus vector. Nature. 1982;299:265–268. [PubMed: 6287291]
  679. Shin C.-G., Taddeo B., Haseltine W.A., Farnet C.M. Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J. Virol. 1994;68:1633–1642. [PMC free article: PMC236621] [PubMed: 8107224]
  680. Shinnick T.M., Lerner R.A., Sutcliffe J.G. Nucleotide sequence of Moloney murine leukemia virus. Nature. 1981;293:543–548. [PubMed: 6169994]
  681. Shoeman R.L., Sachse C., Honer B., Mothes E., Kaufmann M., Traub P. Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease: Actin, desmin, myosin, tropomyosin. Am. J. Pathol. 1993;142:221–230. [PMC free article: PMC1886840] [PubMed: 8424456]
  682. Shoeman R.L., Honer B., Stoller T.J., Kesselmeier C., Miedel M.C., Traub P., Graves M.C. Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, glial fibrillary acidic protein. Proc. Natl. Acad. Sci. 1990;87:6336–6340. [PMC free article: PMC54528] [PubMed: 2201025]
  683. Shugars D.C., Wild C.T., Greenwell T.K., Matthews T.J. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 1996;70:2982–2991. [PMC free article: PMC190157] [PubMed: 8627774]
  684. Sigal C.T., Zhou W.-J., Buser C.A., McLaughlin S., Resh M.D. The amino-terminal basic residues of Src mediate membrane binding through electrostatic interactions with acidic phospholipids. Proc. Natl. Acad. Sci. 1994;91:12253–12257. [PMC free article: PMC45415] [PubMed: 7527558]
  685. Silverman L., Resh M.D. Lysine residues form an integral component of a novel NH2-terminal membrane targeting motif for myristylated pp60v-src. J. Biol. Chem. 1992;119:415–425. [PMC free article: PMC2289653] [PubMed: 1400583]
  686. Simm M., Shahabuddin M., Chao W., Allan J.S., Volsky D.J. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J. Virol. 1995;69:4582–4586. [PMC free article: PMC189210] [PubMed: 7769728]
  687. Skalka A.M. Retroviral proteases: First glimpses at the anatomy of a processing machine. Cell. 1989;56:911–913. [PubMed: 2647305]
  688. Skripkin E., Paillart J.C., Marquet R., Ehresmann B., Ehresmann C. Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. Proc. Natl. Acad. Sci. 1994;91:4945–4949. [PMC free article: PMC43906] [PubMed: 8197162]
  689. Smith A.J., Cho M.I., Hammarskjöld M.L., Rekosh D. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 1990;64:2743–2750. [PMC free article: PMC249454] [PubMed: 1692347]
  690. Smith A.J., Srinivasakumar N., Hammarskjöld M.L., Rekosh D. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 1993;67:2266–2275. [PMC free article: PMC240363] [PubMed: 8445731]
  691. Sodroski J., Goh W.C., Rosen C., Tartar A., Portetelle D., Burny A., Haseltine W. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science. 1986;231:1549–1553. [PubMed: 3006244]
  692. Sommerfelt M.A., Petteway S.R., Dreyer G.B., Hunter E. Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage. J. Virol. 1992;66:4220–4227. [PMC free article: PMC241225] [PubMed: 1602542]
  693. Sonenberg N., Meerovitch K. Translation of poliovirus mRNA. Enzyme. 1990;44:278–291. [PubMed: 1966842]
  694. Sonigo P., Alizon M., Staskus K., Klatzmann D., Cole S., Danos O., Retzel E., Tollais P., Haase A., Wain-Hobson S. Nucleotide sequence of the visna lentivirus: Relationship to the AIDS virus. Cell. 1985;42:369–382. [PubMed: 2410140]
  695. Sonstegard T.S., Hackett P.B. Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76gag. J. Virol. 1996;70:6642–6552. [PMC free article: PMC190705] [PubMed: 8794299]
  696. Sorge J., Hughes S.H. The splicing of intervening sequences introduced into an infectious retroviral vector. Mol. Appl. Genet. 1982;1:547–599. [PubMed: 6296256]
  697. Sorge J., Ricci W., Hughes S.H. cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus. J. Virol. 1983;48:667–675. [PMC free article: PMC255399] [PubMed: 6313966]
  698. Sorge J., Wright D., Erdmann V.D., Cutting A.E. Amphotropic retrovirus vector system for human gene transfer. Mol. Cell. Biol. 1984;4:1730–1737. [PMC free article: PMC368980] [PubMed: 6092935]
  699. Sova P., Volsky D.J. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 1993;67:6322–6326. [PMC free article: PMC238061] [PubMed: 8371360]
  700. Spearman P., Ratner L. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates. J. Virol. 1996;70:8187–8194. [PMC free article: PMC190900] [PubMed: 8892951]
  701. Srinivasakumar N., Hammarskjöld M.L., Rekosh D. Characterization of deletion mutations in the capsid region of human innunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 1995;69:6106–6114. [PMC free article: PMC189507] [PubMed: 7666514]
  702. Stacey D.W. Messenger activity of virion RNA for avian leukosis viral envelope glycoprotein. J. Virol. 1979;29:949–956. [PMC free article: PMC353254] [PubMed: 221682]
  703. Steeg C.M., Vogt V.M. RNA-binding properties of the matrix protein (p19gag) of avian sarcoma and leukemia viruses. J. Virol. 1990;64:847–855. [PMC free article: PMC249180] [PubMed: 2153248]
  704. Stein B.S., Engleman E.G. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J. Biol. Chem. 1990;265:2640–2649. [PubMed: 2406237]
  705. Steinkasserer A., Harrison R., Billich A., Hammerschmid F., Werner G., Wolff B., Peichl P., Palfi G., Schnitzel W., Mlynar E., Rosenworth B. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): Interference with early and late events in HIV-1 replication. J. Virol. 1995;69:814–824. [PMC free article: PMC188647] [PubMed: 7815548]
  706. Stephens E.B., Compans R.W. Nonpolarized expression of a secreted murine leukemia virus glycoprotein in polarized epithelial cells. Cell. 1986;47:1053–1059. [PubMed: 3022940]
  707. Stewart L., Vogt V.M. trans-Acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase. J. Virol. 1991;65:6218–6231. [PMC free article: PMC250316] [PubMed: 1717719]
  708. Stewart L., Vogt V.M. Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells. J. Virol. 1993;67:7582–7596. [PMC free article: PMC238225] [PubMed: 7693975]
  709. Stewart L., Schatz G., Vogt V.M. Properties of avian retrovirus particles defective in viral protease. J. Virol. 1990;64:5076–5092. [PMC free article: PMC248000] [PubMed: 1697912]
  710. Stohrer R., Hunter E. Inhibition of Rous sarcoma virus replication by 2-deoxyglucose and tynicamycin: Identification of an unglycoslyated env gene product. J. Virol. 1979;32:412–419. [PMC free article: PMC353572] [PubMed: 228066]
  711. Stoker A.W., Bissell M.J. Development of avian sarcoma and leukosis virus-based vector-packaging cell lines. J. Virol. 1988;62:1008–1015. [PMC free article: PMC253660] [PubMed: 2828649]
  712. Stoltzfus C.M., Snyder P.N. Structure of B77 sarcoma virus RNA: Stabilization of RNA after packaging. J. Virol. 1975;16:1161–1170. [PMC free article: PMC355715] [PubMed: 171447]
  713. Strambio-de-Castillia C., Hunter E. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 1992;66:7021–7032. [PMC free article: PMC240357] [PubMed: 1279197]
  714. Strebel K., Klimkait T., Martin M.A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 1988;241:1221–1223. [PubMed: 3261888]
  715. Strebel K., Klimkait T., Maldarelli F., Martin M.A. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 1989;63:3784–3791. [PMC free article: PMC250971] [PubMed: 2788224]
  716. Strebel K., Daugherty D., Clouse K., Cohen D., Folks T., Martin M.A. The HIV ‘A’ (sor) gene product is essential for virus infectivity. Nature. 1987;328:728–730. [PubMed: 2441266]
  717. Stromberg K., Hurley N.E., Davis N.L., Rueckert R.R., Fleissner E. Structural studies of avian myeloblastosis virus: Comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Virol. 1974;13:513–528. [PMC free article: PMC355323] [PubMed: 4129794]
  718. Strop P., Konvalinka J., Stys D., Pavlickova L., Blaha I., Velek J., Travnicek M., Kostka V., Sedlacek J. Specificity studies on retroviral proteinase from myeloblastosis-associated virus. Biochemistry. 1991;30:3437–3443. [PubMed: 1849425]
  719. Summers M.F., Henderson L.E., Chance M.R., Bess J.W.J., South T.L., Blake P.R., Sagi I., Perez A.G., Sowder R.C. III, Hare D.R., Arthur L.O. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1992;1:563–574. [PMC free article: PMC2142235] [PubMed: 1304355]
  720. Sundquist W.I., Heaphy S. Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc. Natl. Acad. Sci. 1993;90:3393–3397. [PMC free article: PMC46306] [PubMed: 8475087]
  721. Svoboda J., Dvorak M., Guntaka R., Geryk J. Transmission of (LTR, v-src, LTR) without recombination with a helper virus. Virology. 1986;153:314–317. [PubMed: 3016994]
  722. Swain A., Coffin J.M. Mechanism of transduction by retroviruses. Science. 1992;255:841–845. [PubMed: 1371365]
  723. Swanstrom R., Kaplan A.H., Manchester M. The aspartic proteinase of HIV-1. Semin. Virol. 1990;1:175–186.
  724. Takeuchi Y., Simpson G., Vile R.G., Weiss R.A., Collins M.K. Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. Virology. 1992;186:792–794. [PubMed: 1733113]
  725. Tang J., James M.N., Hsu I.N., Jenkins J.A., Blundell T.L. Structural evidence for gene duplication in the evolution of the acid proteases. Nature. 1978;271:618–621. [PubMed: 24179]
  726. Taniguchi H., Maneti S. Interaction of myristoylated alanine-rich protein kinase C substrate (MARCKS) with membrane phospholipids. J. Biol. Chem. 1993;268:9960–9963. [PubMed: 8486722]
  727. Tchenio T., Heidmann T. The dimerization/packaging sequence is dispensable for both the formation of high-molecular-weight RNA complexes within retroviral particles and the synthesis of proviruses of normal structure. J. Virol. 1995;69:1079–1084. [PMC free article: PMC188679] [PubMed: 7815486]
  728. Teich N. 1984Taxonomy of retroviruses In Molecular biology of tumor viruses, 2nd edition: RNA tumor viruses 1/Text (ed. R. Weiss et al.), pp. 25–207. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
  729. ten Dam E.B., Pleij C.W., Bosch L. RNA pseudoknots: Translational frameshifting and readthrough on viral RNAs. Virus Genes. 1990;4:121–136. [PMC free article: PMC7089070] [PubMed: 2402881]
  730. ten Dam E., Brierley I., Inglis S., Pleij C. Identification and analysis of the pseudoknot-containing gag-pro ribosomal frameshift signal of simian retrovirus-1. Nucleic Acids Res. 1994;22:2304–2310. [PMC free article: PMC523688] [PubMed: 8036158]
  731. Tercero J.C., Wickner R.B. MAK3 encodes an N-acetyl-transferase whose modification of the L-A Gag NH2 terminus is necessary for virus particle assembly. J. Biol. Chem. 1992;267:20277–20281. [PubMed: 1400344]
  732. Tercero J.C., Dinman J.D., Wickner R.B. Yeast MAK3 N-acetyltransferase recognizes the N-terminal four amino acids of the major coat protein (Gag) of the L-A double-stranded RNA virus. J. Bacteriol. 1993;175:3192–3194. [PMC free article: PMC204643] [PubMed: 8491733]
  733. Terry R., Soltis D.A., Katzman M., Cobrinik D., Leis J., Skalka A.M. Properties of avian sarcomaleukosis virus pp32-related pol-endonucleases produced in Escherichia coli. J. Virol. 1988;62:2358–2365. [PMC free article: PMC253392] [PubMed: 2836618]
  734. Terwilliger E.F., Godin B., Sodroski J.G., Haseltine W.A. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc. Natl. Acad. Sci. 1989a;86:3857–3861. [PMC free article: PMC287240] [PubMed: 2726755]
  735. Terwilliger E.F., Cohen E.A., Lu Y.C., Sodroski J.G., Haseltine W.A. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. 1989b;86:5163–5167. [PMC free article: PMC297578] [PubMed: 2472639]
  736. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature. 1994;372:363–365. [PubMed: 7969495]
  737. Thomas D.J., Wall J.S., Hainfeld J.F., Kaczorek M., Booy F.P., Trus B.L., Eiserling F.A., Steven A.C. gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. J. Virol. 1991;65:3797–3803. [PMC free article: PMC241410] [PubMed: 2041094]
  738. Tobin G.J., Sowder R.C., Fabris D., Hu M.Y., Battles J.K., Fenselau C., Henderson L.E., Gonda M.A. Amino acid sequence analysis of the proteolytic cleavage products of the bovine immunodeficiency viurs Gag precursor polypeptide. J. Virol. 1994;68:7620–7627. [PMC free article: PMC237213] [PubMed: 7933153]
  739. Toh H., Kikuno R., Hayashida H., Miyata T., Kugimiya W., Inouye S., Yuki S., Saigo K. Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virus. EMBO J. 1985;4:1267–1272. [PMC free article: PMC554335] [PubMed: 2408886]
  740. Tomasselli A.G., Hui J.O., Sawyer T.K., Staples D.J., Bannow C., Reardon I.M., Howe W.J., DeCamp D.L., Craik C.S., Heinrikson R.L. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. J. Biol. Chem. 1990a;265:14675–14683. [PubMed: 2201691]
  741. Tomasselli A.G., Hui J.O., Sawyer T.K., Staples D.J., Bannow C.A., Reardon I.M., Chaudhary V.K., Fryling C.M., Pastan I., Fitzgerald D.J., Heinrikson R.L. Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates. J. Virol. 1990b;64:3157–3161. [PMC free article: PMC249519] [PubMed: 2161935]
  742. Tong L., Pav S., Pargellis C., Do F., Lamarre D., Anderson P.C. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures. Proc. Natl. Acad. Sci. 1993;90:8387–8391. [PMC free article: PMC47361] [PubMed: 8378311]
  743. Torrent C., Gabus C., Darlix J.L. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer. J. Virol. 1994;68:661–667. [PMC free article: PMC236500] [PubMed: 8289369]
  744. Toth M.V., Marshall G.R. A simple, continuous fluorometric assay for HIV protease. Int. J. Pept. Protein Res. 1990;36:544–550. [PubMed: 2090647]
  745. Tounekti N., Mougel M., Roy C., Marquet R., Darlix J.L., Paoletti J., Ehresmann B., Ehresmann C. Effect of dimerization on the conformation of the encapsidation ψ domain of Moloney murine leukemia virus RNA. J. Mol. Biol. 1992;223:205–220. [PubMed: 1731069]
  746. Tozser J., Gustchina A., Weber I.T., Blaha I., Wondrak E.M., Oroszlan S. Studies on the role of the S4 substrate binding site of HIV proteinases. FEBS Lett. 1991;279:356–360. [PubMed: 2001747]
  747. Tozser J., Weber I.T., Gustchina A., Blaha I., Copeland T.D., Louis J.M., Oroszlan S. Kinetic and modeling studies of S3-S3′ subsites of HIV proteinases. Biochemistry. 1992;31:4793–4800. [PubMed: 1591240]
  748. Tristem M., Marshall C., Karpas A., Hill F. Evolution of the primate lentiviruses: Evidence from vpx and vpr. EMBO J. 1992;11:3405–3412. [PMC free article: PMC556875] [PubMed: 1324171]
  749. Tritch R.J., Cheng Y.E., Yin F.H., Erickson-Viitenan S. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J. Virol. 1991;65:922–930. [PMC free article: PMC239833] [PubMed: 1987379]
  750. Trono D. HIV accessory proteins: Leading roles for the supporting cast. Cell. 1995;82:189–192. [PubMed: 7628010]
  751. Tsuchihashi Z., Kornberg A. Translational frameshifting generates the γ subunit of DNA polymerase III holoenzyme. Proc. Natl. Acad. Sci. 1990;87:2516–2520. [PMC free article: PMC53720] [PubMed: 2181440]
  752. Tucker S.P., Compans R.W. Virus infection of polarized epithelial cells. Adv. Virus Res. 1993;42:187–247. [PMC free article: PMC7130709] [PubMed: 8430520]
  753. Vacca J.P., Dorsey B.D., Schleif W.A., Levin R.B., McDaniel S.L., Darke P.L., Zugay J., Quintero J.C., Blahy O.M., Roth E., Sardana V.V., Schlabach A.J., Graham P.I., Condra J.H., Gotlib L., Holloway M.K., Lin J., Chen I.W., Vastag K., Ostovic D., Anderson P.S., Emini E.A., Huff J.R. L-735,524: An orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc. Natl. Acad. Sci. 1994;91:4096–4100. [PMC free article: PMC43730] [PubMed: 8171040]
  754. Van de Ven W.J., Roebroek A.J., Van Duijnhoven H.L. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases. Crit. Rev. Oncog. 1993;4:115–136. [PubMed: 8420571]
  755. Venaud S., Yahi N., Fehrentz J.L., Guettari N., Nisato D., Hirsch I., Chermann J.C. Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication. Res. Virol. 1992;143:311–319. [PubMed: 1480823]
  756. Verderame M.F., Nelle T.D., Wills J.W. The membrane-binding domain of the Rous sarcoma virus Gag protein. J. Virol. 1996;70:2664–2668. [PMC free article: PMC190120] [PubMed: 8642704]
  757. Verschoor E.J., Hulskotte E.G., Ederveen J., Koolen M.J., Horzinek M.C., Rottier P.J. Posttranslational processing of the feline immunodeficiency virus envelope precursor protein. Virology. 1993;193:433–438. [PubMed: 8382405]
  758. Vicenzi E., Dimitrov D.S., Engelman A., Migone T.S., Purcell D.F., Leonard J., Englund G., Martin M.A. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J. Virol. 1994;68:7879–7890. [PMC free article: PMC237250] [PubMed: 7966578]
  759. Vile R.G., Ali M., Hunter E., McClure M.O. Identification of a generalized packaging sequence for D-type retroviruses and generation of a D-type retroviral vector. Virology. 1992;189:786–791. [PubMed: 1322603]
  760. Vincent M.J., Raja N.U., Jabbar M.A. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: Role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 1993;67:5538–5549. [PMC free article: PMC237957] [PubMed: 8350411]
  761. Vogt V.M. Proteolytic processing and particle maturation. Curr. Top. Microbiol. Immunol. 1996;214:95–131. [PubMed: 8791726]
  762. Vogt V.M., Eisenman R. Identification of a large polypeptide precursor of avian oncornavirus proteins. Proc. Natl. Acad. Sci. 1973;70:1734–1738. [PMC free article: PMC433584] [PubMed: 4352653]
  763. Vogt V.M., Eisenman R., Diggelmann H. Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide. J. Mol. Biol. 1975;96:471–493. [PubMed: 170408]
  764. Vogt V.M., Wight W., Eisenman R. In vitro cleavage of avian retrovirus gag proteins by viral protease. Virology. 1979;98:154–167. [PubMed: 90424]
  765. von der Helm K. Cleavage of Rous sarcoma viral polyprotein precursor into internal structural proteins in vitro involves viral protein p15. Proc. Natl. Acad. Sci. 1977;74:911–915. [PMC free article: PMC430528] [PubMed: 191840]
  766. von Poblotzki A., Wagner R., Niedrig M., Wanner G., Wolf H., Modrow S. Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology. 1993;193:981–985. [PubMed: 8460500]
  767. von Schwedler U., Kornbluth R.S., Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. 1994;91:6992–6996. [PMC free article: PMC44324] [PubMed: 8041734]
  768. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 1993;67:4945–4955. [PMC free article: PMC237882] [PubMed: 8331734]
  769. Voynow S.L., Coffin J.M. Truncated gag-related proteins are produced by large deletion mutants of Rous sarcoma virus and form virus particles. J. Virol. 1985;55:79–85. [PMC free article: PMC254900] [PubMed: 2989562]
  770. Wakefield J.K., Wolf A.G., Morrow C.D. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNALys 3. J. Virol. 1995;69:6021–6029. [PMC free article: PMC189498] [PubMed: 7545240]
  771. Walker F., deBlaquiere J., Burgess A.W. Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. J. Biol. Chem. 1993;268:19552–19558. [PubMed: 7690037]
  772. Walter P., Johnson A.E. Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu. Rev. Cell Biol. 1994;10:87–119. [PubMed: 7888184]
  773. Wang C.T., Stegeman-Olsen J., Zhang Y., Barklis E. Assembly of HIV Gag-β-galactosidase fusion proteins into virus particles. Virology. 1994;200:524–534. [PubMed: 8178440]
  774. Wang C.T., Zhang Y., McDermott J., Barklis E. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 1993;67:7067–7076. [PMC free article: PMC238168] [PubMed: 7693966]
  775. Warmington J.R., Waring R.B., Newlon C.S., Indge K.J., Oliver S.G. Nucleotide sequence characterization of Ty 1-17, a class II transposon from yeast. Nucleic Acids Res. 1985;13:6679–6693. [PMC free article: PMC321985] [PubMed: 2997719]
  776. Watanabe S., Temin H.M. Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc. Natl. Acad. Sci. 1982;79:5986–5990. [PMC free article: PMC347036] [PubMed: 6310558]
  777. Weaver T.A., Panganiban A.T. N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation. J. Virol. 1990;64:3995–4001. [PMC free article: PMC249699] [PubMed: 2164607]
  778. Weaver T.A., Talbot K.J., Panganiban A.T. Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J. Virol. 1990;64:2642–2652. [PMC free article: PMC249442] [PubMed: 2186174]
  779. Weiss C.D., Levy J.A., White J.M. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J. Virol. 1990;64:5674–5677. [PMC free article: PMC248628] [PubMed: 2214033]
  780. Weiss S.R., Hackett P.B., Oppermann H., Ullrich A., Levintow L., Bishop J.M. Cell-free translation of avian sarcoma virus RNA: Suppression of the gag termination codon does not augment synthesis of the joint gag/pol product. Cell. 1978;15:607–614. [PubMed: 214247]
  781. Weldon R.A. Jr., Wills J.W. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J. Virol. 1993;67:5550–5561. [PMC free article: PMC237958] [PubMed: 8394460]
  782. Weldon R.A. Jr., Erdie C.R., Oliver M.G., Wills J.W. Incorporation of chimeric Gag protein into retroviral particles. J. Virol. 1990;64:4169–4179. [PMC free article: PMC247881] [PubMed: 2166812]
  783. Welker R., Kottler H., Kalbitzer H.R., Kräusslich H.-G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specficially cleaved by the viral proteinase. Virology. 1996;219:228–236. [PubMed: 8623533]
  784. Whitcomb J.M., Ortiz C.B., Hughes S.H. Replication of avian leukosis viruses with mutations at the primer binding site: Use of alternative tRNAs as primers. J. Virol. 1995;69:6228–6238. [PMC free article: PMC189520] [PubMed: 7545245]
  785. Wieland U., Hartmann J., Suhr H., Salzberger B., Eggers H.J., Kuhn J.E. In vivo genetic variability of the HIV-1 vif gene. Virology. 1994;203:43–51. [PubMed: 8030283]
  786. Wilcox C., Hu J.S., Olson E.N. Acylation of proteins with myristic acid occurs cotranslationally. Science. 1987;238:1275–1278. [PubMed: 3685978]
  787. Wild C., Dubay J.W., Greenwell T., Baird T. Jr., Oas T.G., McDanal C., Hunter E., Matthews T. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. 1994;91:12676–12680. [PMC free article: PMC45502] [PubMed: 7809100]
  788. Willey R.L., Buckler-White A., Strebel K. Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein. J. Virol. 1994;68:1207–1212. [PMC free article: PMC236563] [PubMed: 8289353]
  789. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 1992a;66:226–234. [PMC free article: PMC238279] [PubMed: 1727486]
  790. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 1992b;66:7193–7200. [PMC free article: PMC240416] [PubMed: 1433512]
  791. Williams D.B. Calnexin: A molecular chaperone with a taste for carbohydrate. Biochem. Cell Biol. 1995;73:123–132. [PubMed: 7576485]
  792. Wills J.W., Craven R.C. Form, function, use of retroviral Gag proteins. AIDS. 1991;5:639–654. [PubMed: 1883539]
  793. Wills J.W., Srinivas R.V., Hunter E. Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products. J. Cell Biol. 1984;99:2011–2023. [PMC free article: PMC2113559] [PubMed: 6094591]
  794. Wills J.W., Craven R.C., Weldon R.A. Jr., Nelle T.D., Erdie C.R. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src. J. Virol. 1991;65:3804–3812. [PMC free article: PMC241411] [PubMed: 1710290]
  795. Wills J.W., Cameron C.E., Wilson C.B., Xiang Y., Bennett R.P., Leis J. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 1994;68:6605–66018. [PMC free article: PMC237081] [PubMed: 8083996]
  796. Wills N.M., Gesteland R.F., Atkins J.F. Evidence that a downstream pseudoknot is required for translational readthrough of the Moloney murine leukemia virus gag stop codon. Proc. Natl. Acad. Sci. 1991;88:6991–6695. [PMC free article: PMC52219] [PubMed: 1871115]
  797. Wills N.M., Gesteland R.F., Atkins J.F. Pseudoknot-dependent readthrough of retroviral gag termination codons: Importance of sequences in the spacer and loop 2. EMBO J. 1994;13:4137–4144. [PMC free article: PMC395336] [PubMed: 8076609]
  798. Wilson W., Braddock M., Adams S.E., Rathjen P.D., Kingsman S.M., Kingsman A.J. HIV expression strategies: Ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell. 1988;55:1159–1169. [PubMed: 3060262]
  799. Witte O.N., Baltimore D. Relationship of retrovirus polyprotein cleavages to virion maturation studied with temperature-sensitive murine leukemia virus mutants. J. Virol. 1978;26:750–761. [PMC free article: PMC525900] [PubMed: 78989]
  800. Witte O.N., Tsukamoto-Adey A., Weissman I.L. Cellular maturation of oncornavirus glycoproteins: Topological arrangement of precursor and product forms in cellular membranes. Virology. 1977;76:539–553. [PubMed: 190766]
  801. Wlodawer A., Erickson J.W. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 1993;62:543–585. [PubMed: 8352596]
  802. Wlodawer A., Gustchina A., Reshetnikova L., Lubkowski J., Zdanov A., Hui K.Y., Angleton E.L., Farmerie W.G., Goodenow M.M., Bhatt D., Zhang L., Dunn B.M. Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. Nat. Struct. Biol. 1995;2:480–488. [PubMed: 7664111]
  803. Wlodawer A., Miller M., Jaskolski M., Sathyanarayana B.K., Baldwin E., Weber I.T., Selk L.M., Clawson L., Schneider J., Kent S.B. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease. Science. 1989;245:616–621. [PubMed: 2548279]
  804. Wolin S.L. From the elephant to E. coli: SRP-dependent protein targeting. Cell. 1994;77:787–790. [PubMed: 8004667]
  805. Wondrak E.M., Sakaguchi K., Rice W.G., Kun E., Kimmel A.R., Louis J.M. Removal of zinc is required for processing of the mature nucleocapsid protein of human immunodeficiency virus, type 1, by the viral protease. J. Biol. Chem. 1994;269:21948–21950. [PubMed: 8071314]
  806. Wong-Staal F., Chanda P.K., Ghrayeb J. Human immunodeficiency virus: The eighth gene. AIDS Res. Hum. Retroviruses. 1987;3:33–39. [PubMed: 3476127]
  807. Wu X., Conway J.A., Kim J., Kappes J.C. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein. J. Virol. 1994;68:6161–6169. [PMC free article: PMC237035] [PubMed: 8083957]
  808. Wu X., Hongmei L., Hongling X., Kim J., Partha S., Natsoulis G., Boeke J., Hahn B., Kappes J. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J. Virol. 1995;69:3389–3398. [PMC free article: PMC189051] [PubMed: 7745685]
  809. Xiang Y., Cameron C.E., Wills J.W., Leis J. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J. Virol. 1996;70:5695–5700. [PMC free article: PMC190537] [PubMed: 8764091]
  810. Xiang Y., Ridky T.W., Krishna N.K., Leis J. Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation. J. Virol. 1997;71:2083–2091. [PMC free article: PMC191297] [PubMed: 9032340]
  811. Yang S., Temin H.M. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 1994;13:713–726. [PMC free article: PMC394863] [PubMed: 8313915]
  812. Yao X.J., Göttlinger H., Haseltine W.A., Cohen E.A. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export. J. Virol. 1992;66:5119–5126. [PMC free article: PMC241384] [PubMed: 1629967]
  813. Yao X.J., Subbramanian R.A., Rougeau N., Boisvert F., Bergeron D., Cohen E.A. Mutagenic analysis of human immunodeficiency virus type 1 vpr: Role of a predicted N-terminal α-helical structure in vpr nuclear localization and virion incorporation. J. Virol. 1995;69:7032–7044. [PMC free article: PMC189623] [PubMed: 7474123]
  814. Yoshinaka Y., Luftig R.B. Murine leukemia virus morphogenesis: Cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand (“immature”) to a collapsed (“mature”) form of the virus core. Proc. Natl. Acad. Sci. 1977a;74:3446–3450. [PMC free article: PMC431601] [PubMed: 410020]
  815. Yoshinaka Y., Luftig R.B. Properties of P70 proteolytic factor of murine leukemia viruses. Cell. 1977b;12:709–719. [PubMed: 72613]
  816. Yoshinaka Y., Luftig R.B. p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15,p12, p30, p10) and can be cleaved in vitro by the MuLV proteolytic activity. Virology. 1982;118:380–388. [PubMed: 6178211]
  817. Yoshinaka Y., Katoh I., Copeland T.D., Oroszlan S. Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proc. Natl. Acad. Sci. 1985a;82:1618–1622. [PMC free article: PMC397323] [PubMed: 3885215]
  818. Yoshinaka Y., Katoh I., Copeland T.D., Oroszlan S. Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease. J. Virol. 1985b;55:870–873. [PMC free article: PMC255078] [PubMed: 2991607]
  819. Yoshinaka Y., Katoh I., Copeland T.D., Smythers G.W., Oroszlan S. Bovine leukemia virus protease: Purification, chemical analysis, in vitro processing of gag precursor polyproteins. J. Virol. 1986;57:826–832. [PMC free article: PMC252811] [PubMed: 3005629]
  820. You J.C., McHenry C.S. HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization. J. Biol. Chem. 1993;268:16519–16527. [PubMed: 8344933]
  821. Young J.A.T., Bates P., Varmus H.E. Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J. Virol. 1993;67:1811–1816. [PMC free article: PMC240233] [PubMed: 8383211]
  822. Young J.A.T., Bates P., Willert K., Varmus H.E. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science. 1990;250:1421–1423. [PubMed: 2175047]
  823. Yu S.F., Baldwin D.N., Gwynn S.R., Yendapalli S., Linial M.L. Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses. Science. 1996a;271:1579–1582. [PubMed: 8599113]
  824. Yu S.F., Edelmann K., Strong R.K., Moebes A., Rethwilm A., Linial M.L. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 1996b;70:8255–8262. [PMC free article: PMC190912] [PubMed: 8970944]
  825. Yu X.F., Ito S., Essex M., Lee T.H. A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature. 1988;335:262–265. [PubMed: 2842694]
  826. Yu X.F., Matsuda M., Essex M., Lee T.H. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J. Virol. 1990;64:5688–5693. [PMC free article: PMC248631] [PubMed: 2145446]
  827. Yu X., Yuan X., Matsuda Z., Lee T.-H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral enveloped protein into mature virions. J. Virol. 1992;66:4966–4971. [PMC free article: PMC241345] [PubMed: 1629961]
  828. Yu X., Yuan X., McLane M.F., Lee T.H., Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 1993;67:213–221. [PMC free article: PMC237354] [PubMed: 8416370]
  829. Yuan X., Yu X., Lee T.H., Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 1993;67:6387–6394. [PMC free article: PMC238073] [PubMed: 8411340]
  830. Yuan X., Matsuda Z., Matsuda M., Essex M., Lee T.H. Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res. Hum. Retroviruses. 1990;6:1265–1271. [PubMed: 2150318]
  831. Zhang Y., Barklis E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 1995;69:5716–5722. [PMC free article: PMC189431] [PubMed: 7637017]
  832. Zhao B., Winborne E., Minnich M.D., Culp J.S., Debouck C., Abdel M.S.S. Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors. Biochemistry. 1993;32:13054–13060. [PubMed: 8241159]
  833. Zhao L.J., Wang L., Mukherjee S., Narayan O. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J. Biol. Chem. 1994;269:32131–32137. [PubMed: 7798208]
  834. Zhao Y., Chen Y., Schutkowski M., Fischer G., Ke H. Cyclophilin A complexed with a fragment of HIV-1 gag protein: Insights into HIV-1 infectious activity. Structure. 1997;5:139–146. [PubMed: 9016720]
  835. Zhou W., Resh M.D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 1996;70:8540–8548. [PMC free article: PMC190946] [PubMed: 8970978]
  836. Zhou W., Parent L.J., Wills J.W., Resh M.D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 1994;68:2556–2569. [PMC free article: PMC236733] [PubMed: 8139035]
  837. Zybarth G., Carter C. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 gag-pol influence PR autoprocessing. J. Virol. 1995;69:3878–3884. [PMC free article: PMC189109] [PubMed: 7745738]
  838. Zybarth G., Kraüsslich H.G., Partin K., Carter C. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J. Virol. 1994;68:240–250. [PMC free article: PMC236283] [PubMed: 8254734]
Copyright © 1997, Cold Spring Harbor Laboratory Press.
Bookshelf ID: NBK19462
Contents

Views

  • PubReader
  • Print View
  • Cite this Page

Related Items in Bookshelf

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...